The association between breastfeeding during late pregnancy and the occurrence of small for gestational age and prolonged active phase of labor among Peruvian women by Pareja de Felipa, Rossina
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2007
The association between breastfeeding during late
pregnancy and the occurrence of small for
gestational age and prolonged active phase of labor
among Peruvian women
Rossina Pareja de Felipa
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Medical Nutrition Commons, Nutrition Commons, and the Obstetrics and
Gynecology Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Pareja de Felipa, Rossina, "The association between breastfeeding during late pregnancy and the occurrence of small for gestational age
and prolonged active phase of labor among Peruvian women" (2007). Retrospective Theses and Dissertations. 15483.
https://lib.dr.iastate.edu/rtd/15483
The association between breastfeeding during late pregnancy and the occurrence of 
small for gestational age and prolonged active phase of labor among Peruvian women 
 
 by 
  
Rossina Pareja de Felipa 
 
 
A thesis submitted to the graduate faculty  
in partial fulfillment of the requirements for the degree of 
 
 
MASTER OF SCIENCE 
 
Major: Nutritional Sciences 
 
Program of Study Committee: 
Grace S. Marquis, Major Professor 
Manju Reddy 
Phillip Dixon 
 
 
 
 
 
 
 
Iowa State University 
Ames, Iowa 
2007 
Copyright © Rossina Pareja de Felipa, 2007. All rights reserved. 
1460092
 
1460092
 2009
 ii
TABLE OF CONTENTS 
 
LIST OF FIGURES ................................................................................................................v 
LIST OF TABLES ................................................................................................................ vi 
ACKNOWLEDGMENTS .................................................................................................. viii 
ABSTRACT .......................................................................................................................... ix 
CHAPTER 1. GENERAL INTRODUCTION .......................................................................1 
        Introduction .....................................................................................................................1 
        Thesis Organization ........................................................................................................2 
CHAPTER 2. LITERATURE REVIEW ................................................................................3 
        Birth weight ....................................................................................................................3 
        Factors associated with birth weight ...............................................................................5 
                Sociodemographic...................................................................................................5 
                Obstetrical history ...................................................................................................6 
                Risk of current pregnancy .......................................................................................7 
         The role of maternal zinc status on birth weight ............................................................9 
           Consequences of being small for gestational age ......................................................12 
                 Short- term consequences ....................................................................................12 
                 Long term consequence .......................................................................................13 
          Breastfeeding-pregnancy overlap ...............................................................................16 
                     Breastfeeding-pregnancy overlap and birth weight .........................................17 
          Zinc during pregnancy and lactation ...........................................................................18 
          Pregnancy and childbirth ............................................................................................20 
          Dystocic labor .............................................................................................................21 
                 First stage ............................................................................................................ 21 
                 Second stage.........................................................................................................21 
          Partograph and Prolonged labor..................................................................................22 
          Zinc and labor .............................................................................................................24 
          Summary .....................................................................................................................25 
 iii 
CHAPTER 3. METHODS ....................................................................................................28 
          Justification of the study .............................................................................................28 
          Study aims ...................................................................................................................28 
          Study site .....................................................................................................................29 
          Study design ................................................................................................................31 
          Ethical approval ..........................................................................................................31 
          Study population .........................................................................................................32 
                 Sample size ..........................................................................................................32 
                 Definition of cases and controls ...........................................................................33 
          Data collection ............................................................................................................35 
          Cross sectional study...................................................................................................37 
          Plasma analysis ...........................................................................................................38 
          Hair analysis................................................................................................................38 
CHAPTER 4.  THE OVERLAP OF BREASTFEEDING DURING LATE PREGNANCY 
AND ITS ASSOCIATION WITH THE RISK OF SMALL FOR GESTATIONAL AGE 
AMONG PERUVIAN WOMEN ..........................................................................................40 
          Abstract .......................................................................................................................40 
          Introduction .................................................................................................................41 
          Participants and methods ............................................................................................43 
          Results .........................................................................................................................46 
          Discussion ...................................................................................................................48 
          Conclusion ..................................................................................................................50 
          References ...................................................................................................................59 
CHAPTER 5.  THE OVERLAP OF BREASTFEEDING DURING LATE PREGNANCY    
IS NOT ASSOCIATED WITH PROLONGED ACTIVE PHASE OF LABOR AMONG 
PERUVIAN WOMEN ..........................................................................................................61 
          Abstract .......................................................................................................................61 
          Introduction .................................................................................................................62 
          Subjects and methods ..................................................................................................64 
 iv
          Results .........................................................................................................................66 
          Discussion ...................................................................................................................69 
          References ...................................................................................................................79 
CHAPTER 6. GENERAL CONCLUSION ..........................................................................81 
           Recommendations for future research .......................................................................81  
GENERAL REFERENCES ..................................................................................................83 
APPENDIX A. ADDITIONAL TABLES ............................................................................92 
APPENDIX B. SURVEY FORMATS ...............................................................................104 
APPENDIX C. INFORMED CONSENT FORMS ............................................................120 
APPENDIX D. TABLE OF BIRTH WEIGHT FOR GESTATIONAL AGE ...................126 
 APPENDIX E. PARTOGRAPH ........................................................................................127 
 
 
 
 
 
 
 
 
 
 
 
 v
LIST OF FIGURES 
 
CHAPTER 2   
Figure 1. Influence of zinc on maternal and infant’s health .................................................09 
Figure 2. Risk factors associated to Small for gestational age .............................................16 
Figure 3.  Friedman’s curve of labor progress ......................................................................23 
CHAPTER 3 
Figure 1. Map of Peru with its physiographic regions and its location in South America ...30 
Figure 2. Location of hospitals in Lima city .........................................................................31 
CHAPTER 4 
Figure 1. Flow of participants enrollment .............................................................................51 
CHAPTER 5 
Figure 1. Flow of participants enrollment .............................................................................72 
 
 
 
 
 
 
 
 
    
 
 
 vi
LIST OF TABLES 
 
CHAPTER 2 
Table 1. Percentage and number of LBW infants by UNICEF regions..................................4 
Table 2. Recommended dietary intake of Zinc in pregnant and lactating women ...............20   
 
CHAPTER 3 
Table 1. Estimations of sample size for aims 1 and 2 ...........................................................32             
Table 2. Estimations of sample size for aims 3 and 4 ...........................................................33 
CHAPTER 4 
Table 1. Maternal sociodemographic characteristics by presence of SGA ..........................52 
Table 2. Household characteristics of SGA cases and their controls ...................................53 
Table 3. Maternal practice of breastfeeding during pregnancy by presence of SGA ...........54 
Table 4. Maternal exposure to recommendations regarding breastfeeding during pregnancy        
by presence of SGA .................................................................................................54 
Table 5. Newborn characteristics of SGA cases and their controls ......................................55 
Table 6. Maternal health behavior during current pregnancy by presence of SGA .............56 
Table 7. Maternal antecedents and health characteristics by presence of SGA ....................57 
 
CHAPTER 5 
Table 1. Maternal sociodemographic characteristics by presence of PAPL .........................73 
Table 2. Maternal breastfeeding practices by presence of PAPL .........................................74 
Table 3. Maternal breastfeeding antecedents by presence of PAPL .....................................74 
Table 4. Maternal health behavior during current pregnancy by presence of PAP L ...........75 
Table 5. Maternal antecedents and health characteristics by presence of PAPL ..................76 
Table 6. Obstetrics procedures during labor by presence of PAPL ......................................77 
Table 7. Newborn characteristics of PAPL cases and their controls ....................................78 
  
APPENDIX 
Table 1. Maternal hair zinc concentration by the presence of BDP .....................................92 
Table 2. Correlation between maternal zinc in plasma and zinc in hair ...............................92 
 vii
Table 3. Household appliances of SGA and their controls ...................................................93 
Table 4. Household members and food expenses by presence of SGA ................................94 
Table 5. Maternal self reported diseases of SGA and their controls ....................................95 
Table 6. Maternal food intake during pregnancy of SGA and their controls .......................97 
Table 7.  Household characteristics of PAPL and their controls ..........................................98 
Table 8. Household appliances of PAPL and their controls .................................................99 
Table 9. Household members and food expenses by presence of PAPL ............................100 
Table 10. Maternal and newborn vital functions during labor of PAPL and their controls100 
Table 11. Maternal self reported diseases of PAPL and their controls ...............................101 
Table 12. Maternal food intake during pregnancy of PAPL and their controls ..................103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
ACKNOWLEDGMENTS 
I thank my best friend and husband, Giancarlo, for all his love, support and 
encouragement since the beginning of this journey. Thanks to my family for continuing to 
show me love and support, even when I was far away. 
I am grateful to Dr. Grace Marquis who gave me the opportunity to achieve this 
important goal in my life, who guided me through my graduate career and who will always 
be an inspiration for my professional life. Thanks to my POS committee, Dr. Manju Reddy 
and Dr. Phillip Dixon who always was patient and willing to answer my questions regarding 
my statistical analysis. 
I would also like to thank all my friends in Peru and USA who helped me throughout 
these years during my research in Peru and making my stay at ISU easier and enjoyable. 
There are many people who supported my research in Peru and I would like thank: 
Dr. Mary Penny and my friends at the Nutritional Research Institute, the obstetricians Celia, 
Mercedes, Veronika and Emma, who worked in the project and the doctors and staff from the 
three hospitals where we conducted the study and supported our work there, Dr. Obando, Dr. 
Vásquez , Dr. Ingar, Dr. Guzmán, Dr. Guerrero, Dr. Mejía and Dr. Castillo. 
Finally, I would like to thank the mothers who participated in this study and also 
CDFIN for partially funding this research. 
 
 
 
 ix
ABSTRACT 
Maternal nutritional status is considered an important risk factor for the progression 
of labor and birth weight. Poor birth outcomes, such as experiencing a prolonged labor or 
being small for gestational age, represent a risk factor for maternal as well as infant 
morbidity and mortality. Understanding the factors that may affect maternal nutritional status 
is necessary. The objective of the present study was to examine the association between the 
practice of breastfeeding during late pregnancy and the risk of having a prolonged active 
phase of labor (PAPL) or giving birth to a small for gestational age (SGA) baby.  
A case-control study was conducted with two matched controls for each case of SGA 
or PAPL. Between March 2006 and April 2007 three Peruvian hospitals were visited daily. 
Mothers who met the inclusion criteria were interviewed and information regarding maternal 
as well as newborn characteristics was extracted from their clinical charts. Hair samples for 
zinc analysis were collected on a subsample of mothers. The association between the overlap 
of breastfeeding during late pregnancy and the risk of SGA or PAPL was tested with 
conditional logistic regression.  
No differences were found in the proportion of mothers who breastfed during late 
pregnancy between the cases of SGA or PAPL and their respective controls.  In addition, 
there was no difference in maternal hair zinc concentration between cases and controls. 
Our findings do not support the hypothesis that the practice of breastfeeding during 
late pregnancy represents a risk for having a small for gestational age infant or experiencing 
a prolonged active phase of labor.  However, research to confirm these results is needed since 
negative birth and postnatal consequences have been previously associated with this practice. 
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CHAPTER 1: GENERAL INTRODUCTION 
Maternal nutritional status is an important determinant of the progression of labor and 
birth outcomes (1).  Pregnant women are among the demographic groups with a highest rate 
of nutritional deficiencies (2-4) even though physiological adjustments, like increased 
absorption of nutrients, help compensate for elevated requirements. Practices that represent 
additional stress for pregnant women can place them even at a higher risk for nutritional 
deficiencies.  One example of additional stress, the practice of breastfeeding during 
pregnancy, implies a higher demand of nutrients since there is the dual cost of fetal 
development and the production of milk. This practice is not uncommon; data from the 
National Health and Nutrition Examination Survey (NHANES) III showed that 5.1% of 
American lactating women were pregnant concurrently (5). A study with Peruvian women 
showed that 10% of pregnant women who had children under 4 years old were also 
breastfeeding during pregnancy (6).  This latter study also showed that after the first month 
of life, infants who were born from mothers who breastfed during the last trimester of 
pregnancy gained 125 g less than infants who were born from mothers who did not 
breastfeed at all during pregnancy. 
A poor birth outcome such as small for gestational age (SGA) not only increases the 
risk of infant morbidity and mortality but also can increase the risk of obesity, coronary heart 
disease and diabetes in adult life (7-9).  Due to the dearth of information regarding 
gestational age there are no estimations of the rates of SGA, but it is estimated that 15.5 % of 
all births worldwide are born with low birth weight (10). In addition, it is estimated that    
529,000 women die annually of causes related to complications during the pregnancy, labor, 
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childbirth and postpartum period (11).  Two of the most common causes of maternal death 
are severe bleeding and sepsis, which frequently are associated with complications during 
labor.  
Prevention of SGA and labor complications such as a prolonged labor can play an 
essential role for improving maternal as well as infant health.  Therefore, it is important to 
examine maternal practices, such as breastfeeding during pregnancy, which may represent a 
risk for the mother and the infant. 
Thesis Organization 
The present thesis starts with a general introduction followed by a thorough literature 
review relevant to the study. In addition, detailed information of the methodology used has 
been included as a separate chapter followed by two manuscripts prepared to be sent to 
scientific journals. The last part includes a chapter with the general conclusions, followed by 
the list of the references used for the first three chapters and the appendices with additional 
results from the study and an example of the instruments used for the data collection.  
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CHAPTER 2: LITERATURE REVIEW 
 
 
Birth weight 
Birth weight is measured during the first hour after birth, before the postnatal weight 
loss occurs and it can be expressed in pounds or kilograms (12).  Although there is still some 
debate about the classification and diagnoses of growth-retarded newborns, the World Health 
Organization (WHO) has set cut-offs to categorize low birth weight. Low birth weight 
(LBW) has been defined as weight at birth less than 2500 g. Although in the past newborns 
who weighted less than 2500 were considered as premature babies, further experience 
showed that many of the infants born with less than 2500 g were not premature babies. Thus, 
officially since 1982 LBW refers to infants born weighing less than 2500 g regardless of 
gestational age (12). This cut-off has been based on epidemiological observations that infants 
weighing less than 2500 g are approximately 20 times more at risk to die than heavier babies 
(10).  
LBW, which is the classification more often used, since gestational age is not 
frequently available, still represents a public health problem in many countries. It has been 
estimated that 15.5 % of all births worldwide are born with low birth weight, from which 
more than 95 % are born in developing countries (10). It is clear that LBW represents a risk 
factor for infants’ health, which is why one of the major goals of the United Nations 
regarding infant health is to reduce LBW incidence at least one third in the present decade 
(10). An estimation of the LBW rates worldwide is shown on Table 1.  
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Table 1. Percentage and number of LBW infants by UNICEF regions  
      
Estimated % of  % of births not  
Number of LBW 
infants 
      
 LBW infants weighed ( in millions) 
Sub-Saharan Africa  14 65 4 
Eastern and Southern Africa 14 63 2 
Western and Central Africa 15 66 2 
Middle East and North Africa 15 60 1 
South Asia    28 74 11 
East Asia and Pacific  8 30 3 
Latin America and Caribbean   9 17 1 
CEE/CIS     7 21 0.5 
Industrialized countries 7 -- 0.8 
Developing countries    16 58 20 
Least developed countries 19 68 5 
World     16 -- 21 
      
      
UNICEF 2000 
Besides LBW, small for gestational age (SGA) is another classification of birth 
outcomes regarding weight which is also important in order to identified newborns at risk. 
SGA is recommended to be used instead of LBW classification, every time the information 
of gestational age is available in order to differentiate low birth weight for gestational age 
from premature newborns.  The Latin-American Center of Perinatology and Human 
Development (CLAP) defines SGA when the birth weight is less than the 10 percentile for 
the gestational age of the newborn (13). CLAP elaborated a table reference of percentiles of 
weight according to gestational age with a sample of 14814 newborns from Brasil, Uruguay 
and Argentina (13).  
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Birth outcomes such as LBW or SGA not only represents an important neonatal 
feature since it represents a significant risk factor for infant morbidity and mortality (10, 12); 
but also birth weight is an important characteristic of pregnancy outcome , given that it 
reflects the intrauterine environment. 
Factors associated with birth weight 
The increased risk for LBW associated with maternal factors such as physiological 
and environmental has been reported by many studies. These characteristics have been 
grouped as follow: 
Sociodemographic Among these factors age is one of the first maternal characteristics that 
has been confirmed as an important risk factor. In 1997, Reichman et al. reported on a 
multivariate analysis from New Jersey data that both mothers, younger than 15 and older 
than 40 y, were at higher risk of having LBW deliveries than 25-29-year-olds (14). Later 
Lasker et al. found a similar trend on a study of 5,528 deliveries in Pensylvania, although the 
cut off for the younger group at highest risk was women younger than 20 years (15).  
Other characteristics such as maternal education and marital status, which are 
interrelated with socioeconomic level, have also been described as important factors 
associated to poor birth outcomes (12, 16-19). Bobak et al. reported a difference of 322 g in 
mean birth weight between infants born to mothers with primary and university education; 
when researchers explored the influence of marital status, they found a difference of 232 g 
between infants born to married and single mothers, (18). A consistent finding was shown by 
Barbieri et al. who reported that among women who had vaginal delivery, the adjusted risk of 
LBW was higher for live births of non-cohabiting mothers (19). Reime et al. suggested that 
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the association between marital status and low birth weight could be because pregnant 
women who are single could have an inadequate prenatal care, they are also more likely to be 
nulliparous, and are under more psychological stress related with their single condition (20).  
In relation to ethnicity, Lasker et al. reported that looking at most reported risk factors 
associated with LBW deliveries, the occurrence of this factors increased more the risk of 
LBW among Latin and African American mothers than for white mothers (15); however as 
reported by Valero de Bernabe et al., it is difficult to attribute these differences only to 
ethnicity, since race it is commonly interrelated with environmental factors which are 
complicated to isolate (12).  
Obstetrical history The first factor reported in this group is parity. Studies have been shown 
that mothers who deliver the first child as well as mothers who deliver the fourth or more, are 
at higher risk of having LBW babies (12, 15, 21, 22). Furthermore, another factor that has 
been found to increase the risk of LBW is the interpregnancy interval. In 1992, Mavalancar 
reported that a short interpregnancy interval was associated with an increased risk of preterm 
delivery while primiparus women had increased risk of term LBW (21). Later, Zhu et al. 
described in a study of 173, 205 birth certificates that newborns who were conceived less 
than 6 months after a live birth, were at higher risk of LBW, preterm birth and SGA (23). 
Short interpregnancy interval has not only been linked to increased risk of the event of LBW 
or SGA but, it also has been associated with a risk of LBW repetition (24). An 
epidemiological case-control study conducted in Chile showed that women who delivered 
LBW babies were more likely to have an history of a previous LBW (25). Consistent with 
this is a study by Abdulrazzaq et al. who studied obstetrical risk factors on indigenous 
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population of United Arabian and found that mothers of LBW infants had a significantly 
higher number of previous LBW deliveries (26).   
Risk of the current pregnancy One of the most important factors related to birth outcomes is 
the nutritional status of pregnant women during the pregnancy period, even important from 
the moment that they become pregnant. Studies on different populations, either from 
developing countries or developed countries, have shown a significant association between 
the prepregnancy weight and LBW (24, 25, 27). Furthermore, another important maternal 
risk factor reported is low pregnancy weight gain. It is not necessary for a women to have 
both of these two mentioned factors to represent a risk, each one separately is considered as a 
significant risk for LBW (22, 25). Strauss et al. reported on two cohorts of approximately 
5000 mothers each, that low weight gain in one of the trimesters of pregnancy , could also 
represent risk for LBW; they found that mothers who had low weight gained either during 
the second or the third trimester of pregnancy, were two times more at risk of LBW (28).  
Besides the direct associations found between pregnancy weight gain and birth 
weight, the weight gain during pregnancy is also a good indicator of the maternal nutritional 
status, which also represents an important factor associated with birth weight (12, 15). Poor 
maternal nutritional status is of concern due to that either before or during pregnancy 
maternal status can be associated to LBW cases (1). In many developing countries not only 
pregnant women, but also childbearing-age women regularly do not meet their nutritional 
requirements, therefore one is likely to find a significant number of women who become 
pregnant without being physically and nutritionally prepared.  A good illustration of this 
problem is the prevalence of iron deficiency; even in a developed country like the US a 
prevalence of 12% iron deficiency has been reported on women of child-bearing age (2). As 
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mentioned before this problem becomes more of concern in developing countries. Jieng et al. 
reported on a study of 1165 Nepali pregnant women of whom 40% were iron deficient and 
20% were deficient in more than one nutrient (3).  
Requirements become very high for many nutrients during pregnancy, which are 
difficult to meet with dietary sources. Consequently it is not surprising to see that the rates of 
nutritional deficiency are high in pregnant women, placing this group of population at higher 
health risk. Ramos Hernandez et al. has reported an inadequate nutritional status in more than 
50% of pregnant women in a peri-urban area of Mexico City who had a poor variety in 
dietary intake, as well as inadequacies in mineral and vitamin intake such as iron, folate and 
zinc (4). In addition, according to Caufield et al. 82% of pregnant women worldwide likely 
have inadequate usual intakes of zinc (29). 
Besides poor dietary intake, maternal nutritional status can be affected by other 
factors; for instance anything that represents an additional physiological stress for the mother 
could account for an increased nutritional requirement. An example of additional 
physiological stress is the practice of breastfeeding during pregnancy, which might be 
thought as an influential factor on maternal nutritional status, as will be discussed later. 
In addition to mother’s nutritional status, other risk factors related to maternal 
behavior during pregnancy have been reported to be associated with birth weight. The first 
and most consistent factor found in many epidemiological studies is the practice of smoking 
during pregnancy (10, 12, 30).  
Finally, even though most of studies published regarding factors associated with birth 
weight have approached LBW as the birth outcome, the same factors have been reported to 
be associated with the occurrence of SGA (31). Gao et al. reported results from a cohort of 
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1398 infants.  Maternal smoking during the third trimester of pregnancy significantly 
increased the risk of having a SGA newborn (32). Although reports about passive smoking 
are not consistent, Han et al. lately have reported on a case control study that passive 
smoking during the second and third trimester of pregnancy was significantly associated with 
an increased risk of SGA (33). Other maternal practices such as alcohol or drug consumption 
during pregnancy have been also cited as risk factors for SGA (10, 12) 
The role of maternal zinc status on birth weight  
Zinc is an essential mineral that is found in almost all the compartments of the human 
body. It plays an important role in more than 100 different enzymes. Among the most 
important roles of zinc are: immune function, neurobehavioral changes, growth and 
development, and maternal health and pregnancy outcome (Figure 1) (34).   
 
Figure 1. Influence of zinc status on maternal and infant’s health 
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One of the first observations that suggested the association between maternal zinc 
status and birth outcomes was that poor pregnancy outcomes were found in women with 
acrodermitis enteropathica (35), a disorder that results in the inability to absorb adequate 
amounts of zinc from the diet. Although the association between maternal zinc status and 
birth outcomes is still subject of studies, researchers have reported some evidence of a 
positive association between maternal zinc status and birth weight (36, 37). Neggers et al. 
reported an 8-fold higher prevalence of low birth weight associated to mothers with serum 
zinc concentration in the lowest quartile compared with the highest quartile (38). A similar 
association, although not conclusive because of the small sample, were reported by De Jong 
et al. (39).  In addition, a study conducted in Tanzania (2005) reported that mothers with low 
zinc levels were two and half time more at risk of having an infant weighing < 2000 g 
compared to those with normal zinc levels (40). Studies that looked at the maternal zinc 
intake during pregnancy have also reported an association with LBW. Scholl et al. studied a 
cohort of 818 pregnant women and found that low zinc intake was associated with increased 
risk of LBW and when the same group compared women with moderate zinc intake vs. 
women with low zinc intake, the latter group doubled their risk of having a LBW newborn. 
(41).  
Regarding zinc status in SGA newborns, Krebs et al. studied preterm newborns 
between 32 and 34 weeks of gestational age and found a smaller exchangeable zinc pool 
(which is the combined pools of zinc in the body that exchange with zinc in plasma) in SGA 
comparing with adequate for gestational age (AGA) newborns (42). 
In addition, some studies that have looked at the effect of maternal zinc 
supplementation on birth outcomes, have described an increment on birth weight associated 
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with the use of zinc supplements by pregnant women. Goldenberg et al. conducted a 
supplementation trial with women who had a low plasma zinc level during early pregnancy; 
this group reported a significant difference in birth weight between infants who were born 
from women who received zinc supplements compared to infants who were born from 
women who did not; although this difference was significant only in women with a body 
mass index (weight in kg/square of height in meters) less than 26 kg/m2 (43). On the other 
hand there have been some studies that have not shown a positive effect of zinc 
supplementation on birth outcomes (44, 45).  
Regarding contradictory findings on supplementation trials, Pérez-Escamilla and 
Pollitt (46) proposed that the lack of significant effect on birth weight could be due to the 
short period of maternal supplementation; these researchers analyzed  the study conducted by 
Villar and Rivera (47) where undernourished mothers from rural Guatemalan villages were 
divided into three treatment groups and a control group; one group received supplements 
during the previous two pregnancies and lactation, the other group received supplements 
during the previous pregnancy and lactation, and the third group that received supplements 
only during the latest pregnancy. This study showed a statistically significant difference on 
birth weight between supplemented and control mothers only in the group that received the 
supplements during two pregnancies and lactation. Therefore, Pérez-Escamilla and Pollit 
suggested that perhaps undernourished mothers need longer periods of supplementation to 
replenish their nutritional reserves, before showing an effect on birth outcomes (46).  In 
addition, other studies where no association between zinc supplementation and birth weight 
was found, reported that one of the reasons for the lack of effect is that mothers who received 
the supplements could have been also deficient in other nutrients that could limited fetal 
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growth (48). In fact, the deficiency of more than one micronutrient in pregnant women has 
been already reported, especially in developing countries.  A study conducted in India looked 
at multiple micronutrient deficiencies among pregnant women. The women were screened 
for 6 micronutrients; more than 50% of the pregnant women were deficient in at least two 
micronutrients (zinc and iron), around 25% were deficient in three (zinc, magnesium and 
iron) and even almost 10% were deficient in four micronutrients (zinc, magnesium, iron and 
folic acid) (49). Following this publication Jiang et al. reported that approximately 18% of 
pregnant women of a rural area of Nepal were deficient in at least five micronutrients (3). 
Even when, as just showed, several studies have looked at the association between 
maternal zinc status and birth outcomes, the mechanism whereby zinc deficiency affects birth 
weight is not known yet. It has been suggested that this association is the result the negative 
effect of zinc deficiency over metabolic functions causing abnormal synthesis of nucleic 
acids and proteins, impaired cellular growth, excessive cell death, among others (35). It has 
been also reported by Simmer et al. that zinc depletion may contribute to intrauterine growth 
retardation by affecting placental and/or umbilical prostaglandins production (50), but more 
research is needed to confirm this association. 
Consequences of being small for gestational age 
Short-term consequences 
One of the most important concerns about being born SGA is the higher risk of infant 
morbidity and mortality that it represents. Martinez et al. reported on a cohort of 12,311 
Spanish infants. The mortality rate in SGA newborns was 5.75 times higher than AGA 
newborns (defined as birth weight between the 10th and 90th percentile for gestational age). 
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They also found in the same study that the proportion of congenital malformations, 
hypocalcemia and hypoglycemia was increased in SGA (51).  Consistent findings have been 
reported previously by Gortnel et al., who besides increased mortality risk also reported an 
increased risk for developing chronic lung disease in SGA newborns (52). Even premature 
babies have shown different neonatal outcomes according to birth weight. Sharma et al. 
compared short-term consequences on SGA and AGA premature babies and reported an 
increased risk of mortality and chronic lung disease in SGA premature babies (53).  
Long term consequences 
It is been more than 10 years since Baker and colleagues introduced for the first time the 
term fetal origins of adult disease, after they found an association between deprived living 
conditions of mothers and an increased risk of stroke in their offspring, suggesting a long 
term effect of nutrition deprivation during early life (54). Later, Baker reported that the 
impairment of fetal growth was associated with an increased risk of obesity, coronary heart 
disease and diabetes in adult life (55). Since then, many epidemiological studies have 
reported consistent findings (7-9), for which this area of research have received more 
attention this last decade.    
What at the beginning was called “fetal programming” referring to fetal adaptative 
responses to a detrimental intrauterine environment (54) now after several studies, especially 
in animals, is called “developmental plasticity”, defined as “the phenomenon by which one 
genotype can give rise to a range of different physiological or morphological states in 
response to different environmental conditions during development” (56). There are changes 
in phenotype development by the fetus in order to adapt to an adverse environment which 
help the fetus to survive. At the same time these changes might have long term consequences 
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that seem to be more evident when a period of impaired fetal growth is followed by a period 
of faster neonatal catch-up growth.  
The mechanism involved in these long term consequences is not clear yet, but some 
hypotheses have been postulated, such as the reduced number of cells in some organs as a 
consequence of undernutrition (55) or the alteration of hormonal systems as a result of the 
exposure to an adverse intrauterine environment, which implicates changes in hormone 
secretion or tissue sensitivity (57).  
Birth weight and obesity The prevalence of obesity has increased not only in developed 
countries, but also in developing countries. The increased risk that obesity represents for 
several chronic diseases has located obesity as focus of many epidemiological studies.  Some 
of these epidemiological studies that looked at the origins and the risk factors associated with 
obesity have found an association between LBW or SGA and obesity, especially with central 
obesity (7-9, 56). Consistent findings have been reported by Rassmussen et al. on a cohort of 
young men where those who were born SGA showed a significant higher fat mass and 
abdominal fat/total fat mass proportion compared with those who were born with normal 
birth weight (defined as birth weight between the 50th and 90th percentile for gestational age) 
(58). It has been observed that these associations between SGA and adiposity are facilitated 
by a faster catch up weight gain. Ibanez et al. studied body composition change in the first 
years of life of SGA and AGA and found that even when both groups gained similar weight 
between 2 – 3 years, children who were SGA gained more abdominal fat and body adiposity 
and less lean mass (59). In addition, Loos et al. who studied young female and male twins 
found differences in body composition between the lighter and the heavier twin where the 
lighter twin showed less lean mass and more subcutaneous fat than the heavier twin (60, 61).  
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Birth weight and chronic diseases After the findings presented by Barker about the 
association of birth weight with chronic diseases in adult life, many investigations have been 
conducted with consistent results. Insulin resistance, an important component of the 
pathology of diabetes, has been investigated in different populations. Yajnik et al. examined 
children at 8 years of age and found that children who were born with the lowest birth weight 
and had a faster catch up, having grown the biggest in the group, presented the highest 
insulin resistance and central adiposity (62). Soto and Mericq looked at changes occurred in 
1 year old infants and found higher levels of fasting insulin in infants who were born SGA 
and had a faster catch up compared to SGA without catch up growth or AGA infants (63). In 
2000 Lawlor studied a cohort of 5,793 subjects who were born between 1950 and 1956 and 
found an increased risk of diabetes in the subjects who were born with lower weight (64). 
A follow up study of 3641 men in Finland on coronary heart disease showed high 
death rates among the subjects who had LBW and had an average or above average body 
mass index at 11 years of age (65). Lawlor et al. reported later in a cohort of post menopausal 
women, an inverse association between birth weight and coronary heart disease (66). It is 
noteworthy that consistent trends have been reported by the same group and other researchers 
(67, 68). 
Birth weight and neurodevelopment In addition to these physical consequences discussed 
above, neurodevelopmental consequences have been reported as well. Van Wassenaer 
reviewed results from different cohort studies and found consistent trend about this 
association. One study showed that SGA babies more often made late entry at secondary 
school; another group who examined subjects at 26 years of age found that those who were 
born SGA less often performed professional work (69). Learning difficulties present at a 
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higher rate in SGA than in AGA. Similar findings were reported by Chaudari et al. who 
examined academic performance of 12 year old children born with less than 2000 g and 
found that it was significantly lower than the performance of same age children who were 
born with more than 2500 g (70). 
Scientific evidence is consistent about these different associations but the 
understanding of the mechanisms involved in the physiological as well as 
neurodevelopmental consequences of LBW or SGA are still under investigation.  
 
Figure 2. Risk factors associated to small for gestational age 
Breastfeeding-pregnancy overlap  
Contrary to what is assumed about the practice of breastfeeding during pregnancy, 
this is not an uncommon practice. Data from the National Health and Nutrition Examination 
Survey (NHANES) III showed that 5.1% of American lactating women were at the same 
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time pregnant (5). This practice is even more common in developing countries; Merchant et 
al. reported on a nutrition-supplementation trial conducted on rural Guatemalan women that 
50.2% of the participants with a child < 7 years were breastfeeding during pregnancy (71). In 
addition, Ramachandran has stated that around 30% of pregnancies in India occur in lactating 
women (72). While there are some mothers who wean their offspring when they find out 
about the new pregnancy, there are mothers who continue breastfeeding until giving birth. 
Marquis et al. on a study of Peruvian pregnant women reported the practice of breastfeeding 
during the last trimester of pregnancy in 10% of the women with a child less than 4 years old 
(6). According to Moscone and Monroe the most stated reason given by mothers to continue 
breastfeeding is the security and comfort of the nursing child (73), therefore it is expected to 
continue finding the practice of breastfeeding during pregnancy in different populations. 
Breastfeeding-pregnancy overlap and birth weight Most of the studies regarding the effects 
of breastfeeding during pregnancy started in animals, with especial interest from dairy 
companies on its association with changes in the quality of milk as well as the milk yield. 
Since the 1950’s until now, effects on the milk yield as well as the milk composition has 
been reported on studies of pregnant cows milked before parturition (74-76); most of these 
effects have been found when the milking continues through late pregnancy. Among the 
consequences of this practice Roche in 2003 reported a reduced milk, protein and fat yield 
during late pregnancy on cows milked during pregnancy compared with their not pregnant 
twins (76).  
At present there are just a few studies on humans that have looked at the practice of 
breastfeeding during pregnancy. The results of these studies suggest a negative effect on the 
birth outcomes, pregnant women’s health, or newborn’s growth. To our knowledge, the first 
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study that looked at the effect of breastfeeding pregnancy overlap on fetal growth was 
conducted by Merchant et al. in 1990 where they found a non-significant 57 g decrease in 
birth weight when they compared babies who were born from mothers who overlapped and 
mothers who did not (71).  A few years later, Siega-Riz and Adair reported on a cohort study 
of Filipino pregnant women that lactation into the third trimester of pregnancy had a 
significant negative effect on maternal pregnancy weight gain, estimating that a women with 
the overlap into this period would gain 1.84 Kg less than a women with an overlap only in 
the first trimester (77). Regarding mother’s weight Ramachandran pointed out, from 
investigations conducted by the National Institute of Nutrition in India, that mothers who 
became pregnant while breastfeeding weighed less during all the trimesters of pregnancy, 
compared to mothers who became pregnant while not breastfeeding (72) .  
It is noteworthy that low weight gain, as was mentioned previously, and especially in 
the third trimester of pregnancy significantly increases the risk of low birth weight (78). 
Finally, Marquis et al. observed in a study of Peruvian pregnant women that after the first 
month of life, infants who were born from mothers who breastfed during pregnancy gained 
125 g less than infants who were born from mothers who did not, in addition these infants 
were also 5 times more likely to have a cough for at least 7 days (6). Until now, there is still a 
gap in the knowledge of possible effects of breastfeeding during pregnancy on the newborn’s 
and mother’s health.  
Zinc during pregnancy and lactation  
Zinc requirements are increased approximately 40-50% for lactating and pregnant 
women compared with women of the same age (Table 2); The increased requirements in 
 19
these two physiological states are due to the zinc needed for synthesis of new tissue, transfer 
of zinc to the fetus, and the cost of the milk production. 
Several studies have looked at the adjustments of zinc homeostasis that occur in 
pregnant or lactating women in order to face the additional demands of zinc during these 
physiological stages. The principal adjustment reported is the increment of fractional zinc 
absorption (FZA). Fung et al. reported significant increased FZA when they compared 
preconception with the lactation period, although a not significant change was reported 
during the pregnancy period (79). Similar findings have been shown later by Sian et al. 
where lactating women had 71% higher FZA during lactation comparing with their 
preconception period (80). In 2005, Donangelo et al. reported on a longitudinal study of 
women with marginal zinc intake that FZA increased significantly during pregnancy and 
lactation (81). Until now there has been no study that has looked at zinc homeostasis in 
women who breastfeed during pregnancy, however it would be expected that when the 
additional requirements of zinc due to lactation are added to those for pregnancy, women 
with poor quality diets, even with increased FZA, will not be able to meet these 
requirements. Hambidge conducted a study of women on their third trimester of pregnancy; 
these women showed an improvement in zinc absorption but they did not meet the 
physiological requirements due to their low zinc intake (82). The estimation that 82% of 
pregnant women worldwide have inadequate zinc intake may explain why, even when there 
are physiological adaptations of zinc absorption, high rates of zinc deficiency are reported in 
pregnant or lactating women.  Not only in developing countries a high prevalence of zinc 
deficiency (>60%) among pregnant women has been reported (3); but also in developed 
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countries. Data extracted from NHANES III showed that approximately only 52% of 
lactating women and 59% of pregnant women had an adequate zinc intake (5).  
Table 2. Recommended dietary intake of Zinc in pregnant and lactating women.   
Age 
Women status 
Non -
Pregnant Pregnant Lactating 
14-18 9 mg 12 mg 13 mg 
19 -30y 8 mg 11 mg 12 mg 
31 - 50y 8 mg 11 mg 12 mg 
Source: Institute of Medicine: "Dietary Reference Intakes 2001” (83) 
 
Pregnancy and childbirth 
The experience of pregnancy and childbirth represents a special period in women’s 
lives, but unfortunately sometimes it can become life threatening with the presence of 
complications, when these complications are not treated adequately.  It is estimated that 
529,000 women die annually of causes related to complications during pregnancy, labor, 
childbirth and postpartum period (11). The distribution of the maternal deaths around the 
world shows that only 1% is represented by developed countries and that of the 20 countries 
with the highest rate of maternal mortality 19 are in Africa, showing once more the higher 
risk at what mothers in developing countries are exposed (11). It has been reported that two 
of the most common causes of maternal death are severe bleeding and sepsis; complications 
during labor are most of the times associated with these outcomes, but, unfortunately there is 
not much information about its prevalence worldwide. Prevention of labor complications or 
early detection with an adequate management could help to reduce maternal mortality, so the 
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understanding of the factors related to these complications is needed in order to prevent 
them. 
Dystocic labor 
Dystocic labor, which indicates difficult labor, is characterized by abnormally slow 
progress of labor due to any complication or circumstance that interferes with the vaginal 
delivery (84). Around the late1950’s Friedman observed the pattern of labor and divided its 
progress in two stages: 
First stage composed by two phases:  
• Latent phase initiates when the mother identifies regular contractions and ends when 
mother has between 4 and 5 cm of dilatation. A prolonged latent phase was defined 
by Friedman as greater than 20 hours for nulliparous and 14 hour for multiparous 
(84). Later WHO defined a prolonged latent phase as cervix not dilated more than 4 
cm after 8 hours of regular contractions (85). 
• Active phase initiates when the mother experiences a dilatation between 4 - 5 cm and 
ends when a dilatation of 10 cm is reached. Friedman defined slow dilatation progress 
as a prolonged active phase when less than 1.2 cm or 1.5 cm of dilatation per hour 
was showed by nulliparous or multiparous respectively (84). According to WHO and 
CLAP prolonged active phase is defined as cervical dilatation’s curve moves to the 
alert line of the partograph and crosses it to the right (86, 87). 
Second stage It begins when the cervical dilatation is complete and ends with the delivery of 
the baby. The average time of the second stage is approximately 50 minutes for nulliparous 
and 20 minutes for multiparous.   
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Complications that interfere with the normal progression of labor have been categorized as 
follow: 
1. Abnormalities of the power includes problems related to uterine contractility and 
maternal expulsive effort.  
2. Abnormalities involving the passenger includes problems related to the position or 
development of the fetus. 
Abnormalities of the passage includes problems with the pelvis (small pelvis for the  
size of the baby).  
Partograph and Prolonged labor 
Since Friedman described the sigmoid curve pattern that cervix dilatation follows 
when graphing against the time (Figure 3), different investigators have developed 
partographs looking for a standard pattern to evaluate labor progress. In the 1990’s CLAP 
developed a partograph, based on the study of the labor of 1188 women, where a dilatation 
progress at the 10 percentile represents the alert line; the cervix dilatation would be graphed 
starting at the active phase according to mother’s parity, position and the condition of the 
membrane (87); In addition, in 1994 a working group organized by WHO, reviewed different 
partographs and developed a standard one with an alert line that represents the cervix 
dilatation expected during the active phase, which should not be slower than 1cm/hour and 
the action line that is placed four hours to the right of the alert line, which represents the time 
where special actions on the labor management should be considered by the health workers 
(85).  The promotion of the use of the partograph by the health professionals is based on the 
key role that this tool plays in the early diagnosis of labor complications (85). However, until 
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now there was not total agreement about the standards that a partograph should follow and 
the time frame to be considered normal for cervical dilatation (88). Some studies have 
suggested that the action line of the WHO partograph is not accurate for the prevention of 
labor complications. Khan and Rizvi reported an increased risk of scar rupture just after 2 
hours of crossing the alert line (89), on the other hand Lavander et al. reported no difference 
between maternal or neonatal outcomes of mothers with labors that were followed with a 
partograph with a 2 hour action line to the right of the alert line comparing with mothers who 
were followed with a partograph with a 4 hour action line (90).   
              
Figure 3.  Friedman’s curve of labor progress (85) 
Nowadays, the problems associated with prolonged labor are not only related with an 
increased risk of perinatal morbidity or mortality, but also there is a psychological 
implication as reported by Nysted et al. on a case-control study; mothers that experienced a 
prolonged labor reported more often the childbirth as a negative experience than normal 
labor women and in some cases they even said that this experience will mark them for life 
(91).  Perinatal mortality and rates of cesarean section can be reduced when there is an early 
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detection of labor complications as well as an adequate management of this complication, 
which can be achieved with an adequate use of the partograph (85). In addition, some studies 
have suggested that an active management of labor, which involves early amniotomy, 2-
hourly vaginal examination and the use of oxytocin for slow progress in labor, could 
decrease the risk of prolonged labor as well as decrease the rate of cesarean sections (92, 93). 
Zinc and labor 
The association between zinc status and labor has been studied both in animals and 
humans. Dura-Trave et al. conducted an experimental study, where one group of rats 
received a zinc-deficient diet and the other group received a normal diet and they reported 
that the group placed in the zinc-deficient diet showed a prolonged labor compared to the 
normal diet group (94). The same group of researchers reported on a study on 336 pregnant 
women, significant association between plasma zinc concentration and duration of the active 
period of delivery; women who had an active phase of labor longer than 10 hours showed 
lower plasmatic zinc levels than women with periods of 10 or less hours, they also found a 
significant association between plasmatic zinc levels and the final mode of delivery (95). 
Consistent findings were described by Lazebnik et al. who studied 279 pregnant women and 
found that lower plasma zinc levels was significantly associated with labor complications 
such as a labor longer than 20 hours, a second stage of labor longer than 2.5 hours; they also 
observed a higher rate of premature rupture of membranes among the women with lower 
alkaline phosphatase levels (96). In addition, Simmer et al. have reported that low zinc 
content in leucocytes was associated with an alteration in their production of prostaglandins, 
especially F2α  (50). Prostaglandin F2α is a prostaglandin that mediates the induction of an 
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enzyme important to establishing the estrogen dominance over the uterus, which makes this 
tissue sensitive to the contractile stimulation, an event that is essential for labor (97).  In 
addition, Sirkoski et al. suggested subnormal zinc content in pregnancy may be a causative 
factor in premature rupture of membranes at term (98). 
Summary 
It has been estimated that infants who weight less than 2500 g (definition of LBW) 
are approximately 20 times more at risk to die than heavier babies. In order to differentiate 
LBW babies from premature babies, the scientific community has recommended classifying 
the birth weight according to the gestational age of the newborn, every time that this 
information is available. The low birth weight for gestational age, better known as small for 
gestational age (SGA), is defined as weight less than the 10th percentile of the reference 
population.  
Among the main factors reported to represent a risk factor for SGA are: 
• Sociodemographic factors such as maternal age, maternal education, marital status. 
• Obstetrical history such as parity and interpregnancy interval. 
• Current pregnancy factors such as maternal nutritional status, low pregnancy weight 
gain.  
The interest in this birth outcome is not only related to the immediate risk that it 
represents for infants’ health, but also on its long term consequences that have been 
associated as result of a phenomenon called “fetal programming” or “ developmental 
plasticity”. SGA has been reported to increase the risk of chronic diseases later in life, such 
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as diabetes, coronary heart disease and increased central adiposity. It is noteworthy that  
neurodevelopment consequences has been associated to poor birth outcomes as well. 
Since maternal nutritional status has been reported to play a key role on birth 
outcomes, additional physiological conditions that could affect maternal nutritional status 
would be expected to also represent a risk for birth outcomes. A practice that can affect 
maternal physiological status and is not as uncommon as it is thought is the breastfeeding 
during pregnancy. This overlap could represent a risk for maternal nutritional status, since it 
increases requirements, making even more difficult for the pregnant women to meet their 
nutritional needs. Although just a couple of human studies have looked at this practice, a 
negative effect on maternal weight gain during pregnancy as well as on infant weight gain 
after the first month of life have been reported. To our knowledge there is still a gap on 
information regarding the association of this practice and birth outcomes. 
A nutrient that has been associated to birth weight due to its important role in growth 
and development is zinc. In addition, this mineral has been also associated with the progress 
of labor; researchers have reported significant differences on the duration of the active phase 
of labor associated to plasmatic zinc levels.  
The progress of labor is very important since complications during this process 
represent a risk not only for the fetus, but also for the mother’s life.  It has been reported that 
two of the most common causes of maternal death are severe bleeding and sepsis, which are 
complications that mainly take place during labor. Perinatal mortality and rates of cesarean 
section can be reduced when there is an early detection of labor complications as well as an 
adequate management of this complication; these can be achieved with an adequate use of 
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the partograph. A partograph is a graphic representation that allows a close monitoring of the 
progress of mothers’ cervix dilatation during labor. 
It is important the prevention of risk factors associated to childbirth complications or 
poor birth outcomes in order to reduce detrimental consequences that can threat infant as well 
maternal health. 
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CHAPTER 3:  METHODS 
Justification of the Study 
The practice of breastfeeding during pregnancy has been reported to occur both in 
developing or developed countries, but until now no evidence based recommendation has 
been formulated by health professionals about this practice due to the lack of information 
available. There have been some suggestions of possible negative effects of this practice on 
birth weight as well as pregnancy weight gain and infant health during the first month of life, 
yet conclusive evidence is not yet available. Therefore, it is important to determine the 
effects of this practice, in order to develop adequate recommendations for the community.  
Study aim 
1. Determine the association of lactation-pregnancy overlap and the occurrence of low 
birth weight for gestational age births.   
Hypotheses 1a. An overlap increases the risk of low birth weight for gestational age 
births. 
2. Determine the association of a lactation-pregnancy overlap on the occurrence of 
prolonged active phase of labor.   
  Hypotheses 2a. An overlap increases the risk of prolonged active phase of labor. 
3.   Determine whether maternal zinc status is associated with a lactation-pregnancy 
overlap.  
Hypotheses 3a. An overlap of lactation and pregnancy is associated with decreased 
maternal zinc status. 
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4. Determine whether maternal zinc status is associated with the occurrence of low birth 
weight for gestational age and prolonged active phase of labor. 
Hypotheses 4a. The risk of prolonged active phase of labor is increased with 
decreased maternal zinc status.  
Hypotheses 4b. The risk of low birth weight for gestational age is increased with 
decreased maternal zinc status. 
Study site 
Peru is the third largest country in South America (Figure 1). The current population 
of Peru is 27,219, 264 (99). According to its physiographic characteristics Peru is divided in 
3 major regions: the coastal region, the highlands and the rainforest. The study was 
conducted in the City of Lima, capital of Peru. Lima is located on the coastal region with a 
total of 6, 954, 583 of inhabitants (99).  
The study was conducted in coordination with the Instituto de Investigación 
Nutricional, a Peruvian non-governmental organization with more than 30 years of research 
experience in the field of nutrition. 
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Figure 1. Map of Peru with its physiographic regions and its location in South America  
 
Hospitals The three hospitals where the study was conducted are among the hospitals with 
the highest rates of attended births in Lima. The three hospitals were located in 3 of the 43 
districts in Lima (Figure 2): 
• Maria Auxiliadora Hospital, with a total of 7,453 births on 2006; it is located in the 
district of San Juan de Miraflores (# 29 on Figure 2)  
• San Bartolome Mother-Child National Teaching Hospital, with a total of 7,637 births 
on 2006; it is located in the district of Cercado de Lima (# 1 on Figure 2) 
• Hipolito Unanue Hospital, with a total of 9,378 births on 2006; it is located in the 
district of El Agustino (# 10 on Figure 2) 
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   Figure 2. Location of hospitals in Lima city 
 
Study design 
This was a case-control study designed to have two matched controls for each case. In 
addition we had a nested case-control in this study designed to have one control matched to 
one case for the samples collected for the analysis of zinc status. 
Ethical approval  
The study was reviewed and received the ethical approval from five institutions: the 
Institutional Review Board of Iowa State University and the ethical committees of The 
Instituto de Investigación Nutricional and the three hospitals where the study was conducted.  
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Study population 
The participants were mothers > 18 years old who gave birth at any of the three 
hospitals and met the inclusion criteria for the study: 
1) Mother agreed to participate. 
2) Labor started spontaneously. 
3) Newborn is a single, live birth. 
4) Newborn has a sibling <4 y living with the family and who was breastfed at birth. 
Sample size 
The calculations for the sample size (Table 1) were made considering two controls 
per case, a two-tailed test, significance level of 0.05 and power of 80%. Considering the 
probability of lactation-pregnancy overlap among the cases and the controls for each study, 
the odds ratios used for the calculation were from Marquis’ preliminary data that documented 
the incidence of LBW and dystocic labor. 
 
Table 1. Estimations of sample size for aims 1 and 2 
Outcome 
  
Odds ratio for 
overlap   
Probability of 
overlap   
Sample size 
    Cases Controls   Cases Controls 
Small for gestational  age 1.6  14.6% 9.67%  367 734 
Prolonged labor   1.9   13.0% 3.9%  170 340 
 
The calculations for the sample size (Table 2) were based on zinc values reported from 
previous studies and Marquis’ preliminary data. 
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Table 2. Estimations of sample size for aims 3 and 4 
Outcome    Published zinc values Mean group difference 
Sample per 
group 
Zinc status1 
 
Overlap: 2.89 +/- 0.21 mg/L 
8% 23 
   
No overlap: 3.13 +/- 0.35 mg/L 
          Small for gestational  
age2 
 
LBW: 62.34 +/- 33.0 µg/dL 
30% 40 
   
Normal: 89.5 +/- 51.4 µg/dL 
          Prolonged  labor3 
 
Dystocic: 65 +/- 21 µg/dL 
22% 21 
      Normal: 83 +/- 17.0 µg/dL 
1Marquis unpublished results; 2Bogden et al. 1978; 3Durá-Trave 1984. 
 
Definitions of cases and controls  
The cases were mothers who delivered low birth weight for gestational age babies or 
mothers with prolonged active phase of labor.  
Low birth weight for gestational age (SGA) A case was defined using the same criteria used 
by the Latin-American Center of Perinatology and Human Development (CLAP) which 
defines SGA as birth weight less than the 10 percentile for the gestational age of the 
newborn.  
The controls of SGA cases were defined as newborns with a birth weight over the 50 
percentile and under the 90 percentile according to their gestational age. 
The reference used to classify the cases and controls was the table of weight for gestational 
age elaborated by CLAP (appendix D). In order to explore the interactions of breastfeeding – 
pregnancy overlap during the third trimester of pregnancy, where the highest amount of 
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weight is gained by the fetus, newborns with a gestational age < 33 weeks at birth were not 
included, as well as post mature newborns (gestational age > 41 weeks). 
Besides the inclusion criteria mentioned previously, the controls were matched to the 
cases according to hospital of delivery, gestational age and interpregnancy interval. The 
interpregnancy interval was divided in 3 groups:    
• 9 - 21 months 
• 22 – 34 months 
• 35 – 47 months 
Prolonged active phase of labor (PAPL) A case was defined as mother with a cervical 
dilatation curve that crossed the alert line to the right on the partograph. The partograph used 
by the three hospitals to control mother’s labor was the one developed by CLAP (appendix 
E). 
The controls of PAPL were defined as mothers with cervical dilatation curve that did 
not cross the alert line on the partograph, without receiving any medication to improve the 
progress of dilatation. 
In addition to the same inclusion criteria, controls were matched to cases according to 
the initial examination of cervical dilatation; the initial report of cervical dilatation of the 
control had to be at least at the same initial dilatation reported on the case (i.e. if the initial 
point on the curve of the case was at 5 cm of dilatation, the control had to have the initial 
point also at not higher than 5 cm of dilatation). The controls were matched also according to 
the hospital of delivery and interpregnancy intervals, having the same grouping like the study 
of SGA.  
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Lactation-pregnancy overlap To compare the zinc status between mothers who overlap and 
did not overlap, a case of lactation-pregnancy overlap was defined as mother who continued 
breastfeeding her child < than 4 years, during the third trimester (from 7th to 9th month) of 
pregnancy. A control was defined as mother who did not breastfeed her child < than 4 years 
while pregnant.  Here, cases were also matched to controls according to hospital of delivery 
and interpregnancy intervals.    
Data collection 
Each hospital was visited every day by a trained health professional who screened all 
the births that occurred after the last visit. Each birth screened according to the inclusion 
criteria was reported on an enrollment form. Once a possible case or control for the SGA or 
PAPL study was identified, the mother was approached, at least 6 hours after delivery, by the 
health professional who invited her to participate in the study. In order to be able to match 
the controls to their respective cases, the health professional identified the case first. 
After the mother agreed to participate and the informed consent form (appendix C) 
was signed, the health professional interviewed the mother using the tools (appendix B) 
developed for collecting information regarding: 
• Sociodemographic. 
• Breastfeeding-lactation overlap. 
• Food frequency intake during pregnancy. 
After the interview, the health professional reviewed the mother’s and newborn’s 
clinical chart to extract information regarding: 
• Newborn (e.g., weight, length, gestational age, Apgar scores) 
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• Labor, for the study of PAPL (e.g., vital functions, cervical dilatation vs. time, use of 
oxytocin, state of membranes, obstetrical procedures) 
• Obstetrical records (e.g., # of deliveries, type of previous deliveries, weight gained 
during pregnancy, hemoglobin). 
The gestational age used, as first option, was the one calculated with the last date of 
menstruation (when mother was sure of this date) which was confirmed with postnatal age 
calculated with a clinical-neurological examination of the newborn (Capurro’s method), 
looking for a consistent calculated age (difference <  than 2 weeks between the two 
methods). Additionally, among the cases and controls enrolled for the studies of SGA and 
PAPL, the health professionals were also identifying the cases and controls of lactation-
pregnancy overlap. Once a mother was identified as a possible participant for the comparison 
of zinc status (aim 3 and 4), she was also invited to participate in that part of the study, in 
addition to the interview. 
Zinc status Since mothers were enrolled and interviewed at the hospitals some hours after 
delivery, the sample collected for the zinc analysis was hair, because blood was not going to 
be a reliable assessment due to the mothers’ physiological changes after delivery. 
Hair samples were collected from the occipital portion of the head and as close as 
possible to the scalp with stainless steel scissors using a stainless steel scissors. For the 
analysis, the proximal 2.0 cm (cut in a < 1cm length pieces) were retained in a small 
polyethylene bottle that was previously washed with a special detergent and EDTA to ensure 
its zinc-free condition. Hair samples were taken, at room temperature, to the laboratory at the 
IIN for the analysis by Atomic Absorption Spectrophotometry (100). 
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Cross Sectional study 
Since we were using the hair samples to compare the zinc status between the cases 
and controls during late pregnancy, we planned to explore if there was an association 
between zinc status determined in blood taken at the 7th month of pregnancy and zinc status 
determined in hair samples taken during the 48 hours after delivery. 
Study site The study was conducted in Canto Grande, located in San Juan de Lurigancho, 
district of Lima, where the IIN has been carrying out field research for more than 20 years 
and currently is conducting other studies. 
Study population The participants were pregnant women > 18 y in the 7th month of 
pregnancy, who agreed to participate and who were having a single pregnancy. 
Data collection Mothers in their 7th month of pregnancy were identified and visited at home 
by field workers of the IIN. After mothers signed their informed consent form field workers 
set an appointment with each one to visit the IIN’s office located in Canto Grande where 
blood samples were going to be taken by a health professional. Overnight fasting blood 
samples were taken by venipuncture using stainless steel needles and trace-element free 
evacuated tubes (LH-Metall-Analytik: SARSTEDT Monovette). After the blood sample was 
taken it was left to settle for 30 minutes after what it was centrifuged at 7000 rpm for 10 
minutes. Plasma was separated and stored in 2.5 ml mineral-free vials and stored at -20 oC.  
After delivery the same mothers were asked for hair samples. Hair samples were 
collected from the occipital portion of the head and as close as possible to the scalp with 
stainless steel scissors. The hair closest to the scalp was retained for the zinc analysis.  The 
length of the sample represented the hair growth between the date when the blood sample 
was taken and date of the delivery.  This length was calculated considering an average hair 
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growth of 1 cm per month.  Hair samples were collected in the same type of small bottles as 
the case-control studies. 
Plasma analysis The sample was diluted 5 times with water type I. The analysis was 
conducted against zinc standards prepared in 5% glycerol to approximate the characteristic 
viscosity of the sample diluted. The samples and the standards were read in the 
spectrophotometer, using zinc lamps at the wave of 214 nm. Reference material (NIST - 
1577b bovine liver certified by the National Institute of Standards and Technology, 
Gaithersburg, MD) was prepared by the laboratory following the same process used for the 
plasma samples. This material was used to monitor the precision of the analysis.  
Human hair analysis 
Each sample (approximately 0.1g of weight) was mixed to insure homogeneity; then 
it was washed in a 150 ml containing 70 ml of a 1% solution of non-ionic detergent, by 
agitating on a mechanical mixer for 30 minutes at room temperature. After that, the sample 
was transferred to a polyethylene filter crucible and rinsed with a total of 500 ml of Type I 
ultra pure water. Following, the hair was dried overnight at 100°C, weighed and transferred 
to a 10 ml Erlenmeyer flask. Dry weight had to be about 0.1 g. Nitric acid (3 ml) was added 
and it was allowed to react at room temperature overnight. The digested product was warmed 
to 100°C for 3 hr after what 0.5 ml of HCLO4 was added and heated at 200°C until dense 
white fumes were evolved. The solution had to be water clear. Final volume was made up to 
5 ml with Type I ultra pure water. 
Analysis by the atomic absorption spectroscopy The standards for Zn were prepared by 
diluting the stock standard solution with Type I ultra pure water. The standards and blank 
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solution were prepared using the same acid levels used for samples preparation. In addition, a 
certified reference hair was obtained from the National Institute for Environmental Studies 
(certified reference material No 13, Tsukuba, Ibaraki) in order to control analytical accuracy. 
This certified reference hair followed the same procedure used for the hair samples. 
The samples were read in the atomic absorption spectrophotometer with a wave 
length of 214 nm, using the zinc lamp. Each sample followed a complete reading cycle twice.  
The zinc results were obtained by linear regression of the standard curve and expressed as 
µg/g. 
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CHAPTER 4: AN OVERLPAP OF BREASTFEEDING DURING LATE 
PREGNANCY DOES NOT INCREASE THE RISK FOR SMALL FOR 
GESTATIONAL AGE AMONG PERUVIAN WOMEN 
 
A paper to be submitted to Pediatrics 
Rossina G. Pareja*, Grace S. Marquis*, Mary Penny†,  
 
Abstract 
Objective The purpose of this study was to investigate if there was an association between 
the practice of breastfeeding during late pregnancy (third trimester) and the risk of having a 
small for gestational age (SGA) infant. 
Participants and methods A case-control study was conducted with two matched controls 
for each case. Between March 2006 and April 2007 three Peruvian hospitals were visited 
daily. A case of SGA was defined as birth weight bellow the 10th percentile for gestational 
age; a control was defined as birth weight over the 50th and under the 90th. Mothers who met 
the inclusion criteria were interviewed and information regarding maternal as well as 
newborn’s characteristics was taken from their clinical charts. Hair samples for zinc analysis 
were collected on a sub sample of mothers. The association between the overlap of 
breastfeeding during late pregnancy and the risk of SGA was tested with conditional logistic 
regression.   
Results 78 cases and 150 controls were included in the analysis. An overlap of breastfeeding 
during late pregnancy was not associated with an increased risk of being SGA; 14 controls 
___________________ 
*
 Department of Food Science and Human Nutrition, Iowa State University, USA. 
†
 School of Dietetics and Human Nutrition, McGill University, Canada. 
‡
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  vs. 3 cases had an overlap; odds ratio = 0.41, 95% CI= 0.11, 1.47). Compared to the 
controls, mothers in the SGA group were less likely to be married (p = 0.042), gained less 
weight during pregnancy (p = 0.004), were more likely to have a female child (p = 0.001), 
and had a previous child born with lower weight (p < 0.000). There was no group difference 
in maternal hair zinc concentration (cases = 168.43 + 30.41 µg/g vs. controls = 163.90 + 
30.41 µg/g; p = 0.568). 
Conclusions Our results do not support the hypothesis that breastfeeding during pregnancy 
increases the risk for SGA.  Health professionals should be cautious about recommending an 
overlap in late pregnancy due to other possible negative consequences of this practice that 
have been previously reported. 
___________________ 
Key words:  breastfeeding, pregnancy, small for gestational age, maternal weight gain 
Abbreviations: SGA- Small for gestational age, CLAP - Centro Latinoamericano de Perinatología y Desarrollo 
Humano. 
 
 
Introduction 
Low birth weight for gestational age, commonly referred to as small for gestational 
age (SGA),  not only represents a significant risk factor for infant morbidity and mortality (1, 
2) but also it has been associated with long-term consequences such as central obesity (3, 4) 
higher levels of fasting insulin (5) and coronary heart disease (6). Birth weight is an 
important pregnancy outcome that reflects the intrauterine environment. This environment 
can be influenced by poor maternal nutritional status, representing a risk factor for SGA (1, 
7, 8).  
In many developed and developing countries pregnant women regularly do not meet 
their nutritional requirements. Caufield et al. estimated that around 82% of pregnant women 
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worldwide do not have an adequate intake of zinc (9).  Jieng et al. reported on a study of 
1165 Nepali pregnant women that 40% were iron deficient and 20% were deficient in more 
than one nutrient (10). Requirements become very high for many nutrients during pregnancy, 
which are difficult to meet with dietary sources. Consequently, it is not surprising to see that 
the rates of nutritional deficiency are high in this group.  
Besides poor dietary intake, maternal nutritional status can be affected by other 
factors, including additional physiological stresses that may increase nutritional requirements 
and place some women at even higher risk of nutritional deficiencies during pregnancy. One 
example of such a physiological stress is the practice of breastfeeding during pregnancy, a 
behavior that in many areas of the world is not an uncommon practice. Data from the 
National Health and Nutrition Examination Survey III showed that 5.1% of lactating U.S. 
women was pregnant (11). Merchant et al. reported on a nutrition-supplementation trial 
conducted among Guatemalan women.  Among these rural women, 50.2% of the participants 
who had a child < 7 years were breastfeeding during their current pregnancy (12). In 
addition, Ramachandran found that around 30% of pregnancies in India occurred in lactating 
women (13). Recently, Marquis et al. reported the practice of breastfeeding during the last 
trimester of pregnancy in 10% of the Peruvian women who had a child under 4 years of age 
(14).  
We hypothesized that the practice of breastfeeding until late pregnancy (the last 
trimester of pregnancy) would increase the risk of having a SGA infant and that zinc status 
among mothers with SGA infants would be lower than zinc status of mothers with normal 
birth weight infants.  
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Participants and methods 
Study site 
The study was conducted at three government hospitals in Lima, Peru: Maria 
Auxiliadora Hospital (southern Lima), San Bartolome Mother-Child National Teaching 
Hospital (north-central Lima), and Hipolito Unanue Hospital (east-central Lima).  The 
hospitals were chosen because each had a high rate of attended births and an overlap of 
breastfeeding during late pregnancy was common among prenatal clinic clients.  
Study design 
This was a case control study designed to have two matched controls for each case. In 
addition, we incorporated a nested case-control with one control matched to one case for the 
analysis of maternal zinc status. 
Ethical approval  
The study was reviewed and received the ethical approval from the Institutional 
Review Board of Iowa State University and the ethic committees of the Instituto de 
Investigación Nutricional (IIN) and the three collaborating hospitals. 
Participants 
The participants were mothers at least 18 years of age who gave birth at any of the 
three hospitals and met the inclusion criteria for the study:  
1) labor started spontaneously;  
2) newborn was a single, live birth; and  
3) newborn has a sibling <4 y living with the family and who was breastfed at birth. 
Definition of cases and controls A case was a SGA newborn defined as having a birth 
weight less than the 10th percentile for gestational age, using the criteria of the Latin-
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American Center of Perinatology and Human Development (CLAP) (15). A control was 
defined as newborn with a birth weight over the 50th percentile and under the 90th percentile 
for gestational age. In addition, controls were matched to the cases according to hospital of 
delivery, gestational age and interpregnancy interval (time between delivery of last child and 
birth date of newborn). The interpregnancy interval was categorized into 3 levels: 9 - 21 
months, 22 – 34 months, 35 – 47 months.   
To examine the effect of breastfeeding pregnancy overlap during late pregnancy 
when the greatest amount of weight is gained by the fetus, newborns with a gestational age < 
33 weeks at birth were not included.  Post-mature newborns (gestational age > 41 weeks) 
were also excluded.  
Data collection  
Each hospital was visited every day by a trained health professional who screened 
all the births that occurred since the last visit. To be able to match the controls to their 
respective cases, the health professional identified a case first. Mothers were approached for 
enrollment at least 6 hours after delivery. Participants were interviewed about their 
sociodemographic characteristics, breastfeeding-pregnancy overlap practice and food 
frequency intake during pregnancy. After the interview, the health professional reviewed the 
mother’s and newborn’s clinical chart to extract information regarding maternal (e.g., 
prenatal control, obstetrical records, hemoglobin) and newborn (e.g., birth weight, length, 
Apgar scores) characteristics.  Birth weight was measured using a digital calibrated scale 
with a capacity of 22 kg and a precision of 5 g that was provided to each hospital. Gestational 
age was calculated using the last date of menstrual period. In cases where the mother was not 
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sure about this date we compared this gestational age to the one calculated with Capurro’s 
method (16); if the difference between the two methods was greater than two weeks, the 
mother was not considered for enrollment. 
 A subsample of mothers provided hair samples for zinc analysis. Hair samples were 
collected from the occipital portion of the head and as close as possible to the scalp using 
stainless steel scissors. For the analysis, the proximal 2.0 cm (cut in < 1 cm length pieces) 
were retained in a small polyethylene bottle. Hair samples were taken, at room temperature, 
to the laboratory for the analysis by the atomic absorption spectrophotometer (17). A 
certified reference hair was used from the National Institute for Environmental Studies 
(certified reference material No 13, Tsukuba, Ibaraki) to assure quality control.  
Data analysis 
Comparisons between cases and controls for continuous variables were made using 
analysis of variance, with the matched case-controls treated as blocks. Comparisons between 
case and controls for categorical variables were made using Pearson 2. A conditional 
logistical regression was used to explore the risk of breastfeeding during late pregnancy on 
the occurrence of SGA. This is a model used for matched case-control designs, where a 
relationship between the binary outcome of interest (SGA) and a binary predictive factor 
(breastfeeding during late pregnancy) was tested. This is a model used for matched case-
control designs, where a relationship between the binary outcome of interest (PAPL) and a 
binary predictive factor (breastfeeding during late pregnancy) was tested.  The analyses were 
conducted using SYSTAT version 9.0 (SPSS, Chicago, IL). Statistical significance was set at 
p < 0.05. 
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Results 
Study participants 
Between March 2006 and April 2007 a total of 21,534 deliveries were screened 
(Figure 1).  The general inclusion criteria was met by 2587 mothers;  of the 1250 women 
who met the criteria for cases or controls, 261 mothers were invited to participate.  Fourteen 
women refused. Most of the women who met the inclusion criteria but did not participate in 
the study were women who were not randomly selected as controls. A total of 95 cases and 
150 controls were enrolled. Of the 95 cases of SGA, 17 were excluded from the analysis due 
to the lack of any matched control. A total of 78 cases and 150 controls were included in the 
analysis.  
A subsample of 74 women provided hair samples for zinc analysis. Fourteen cases 
were excluded due to the lack of a matched control, thus the maternal hair zinc concentration 
of 30 cases and 30 controls were analyzed. 
Maternal sociodemographic characteristics 
There were few differences in the sociodemographic characteristics between SGA 
and non-SGA mothers (Table 1). Mothers of SGA newborns were about a year and a half 
younger (p = 0.046).  They were also less likely to be married and about twice as the 
proportion of women were single women as compared to the control group (p = 0.042). No 
differences were found in maternal housing characteristics (Table 2). 
Maternal practice of breastfeeding during late pregnancy  
A total of 42.5% of mothers reported that they breastfed during the current 
pregnancy; 18.9% of the women continued breastfeeding during the second trimester and 
7.5% still continued during the third trimester. Fourteen non- SGA mothers overlapped 
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breastfeeding during late pregnancy vs. only 3 SGA mothers (Table 3); the average 
frequency of breastfeeding episodes per day was similar between cases and controls (2.7 + 
2.1 vs. 2.9 + 1.8) An odds ratio of 0.41 was found for the risk of breastfeeding during late 
pregnancy for the occurrence of SGA. 
In addition, many women reported receiving recommendations regarding 
breastfeeding during pregnancy; a significantly higher proportion of mothers from the control 
group received recommendations from relatives compared to case mothers (Table 4).  
Newborn’s characteristics 
The average gestational age in the cases as well as in the controls was 38.7 + 0.2 
weeks. Besides the expected difference in birth weight between cases and controls, a 
significant difference was observed in the newborn’s length, where controls were 
approximately 3.5 cm longer than cases (p < 0.000) (Table 5). A significant difference was 
also found in the distribution of females to males; around 67% of the cases were female vs. 
44% in the control group. 
Maternal obstetrics and health characteristics 
There were no differences between cases and controls regarding maternal health 
behaviors during the current pregnancy, such as use of medicines, smoking, or supplement 
use (Table 6). 
There were significant group differences in anthropometric measurements of the 
mother and her previous child. The birth weight of the last child in the control group was 
around 500 g higher than among the cases (p < 0.000) (Table 7). A significant difference in 
maternal weight gained during the current pregnancy was also observed, with a higher weight 
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gain in the control group (p = 0.004).  Mothers in the control group were also taller than 
mothers in the case group (p = 0.007). 
Maternal food frequency intake 
Although a wide range on monthly food frequency intake was observed on most food, 
mothers from the control group consumed more meat, such as beef or pork  (p = 0.030) and 
chicken liver (p = 0.046), approximately two times more per month (data not shown). 
Maternal zinc status  
Maternal hair zinc did not differ between women who gave birth to a SGA baby and 
women with a normal birth weight baby (cases = 168.43 + 30.41 µg/g vs. controls = 163.90 + 
30.41 µg/g; p = 0.568). 
The zinc concentration of the certified reference material, used to control the quality 
of the analysis, was 172 + 11 µg/g (National Institute for Environmental Studies ) and the 
mean value obtained in our laboratory was 170.0 + 3.2 µg/g. 
Discussion 
To our knowledge this is the first study that has looked at the association between the 
practice of breastfeeding during late pregnancy and SGA. Contrary to what we hypothesized, 
our results showed that this practice did not increase the risk of SGA. The proportion of 
mothers in the case group who reported to breastfeed during late pregnancy was very low 
compared to the average found in the present study and that reported previously among 
Peruvian women (14). Since mothers were interviewed after delivery, they were aware of 
their birth outcomes which could have influenced maternal response regarding breastfeeding 
during pregnancy.  This feeding behavior is discouraged in the Peruvian culture and this may 
49 
 
have lead to a biased reporting, with higher denial among mothers delivering an SGA baby.  
The only other study that examined the association between birth weight and a breastfeeding-
pregnancy overlap (at any trimester) reported a non-significant +57g difference in birth 
weight in infants who were born to mothers who had not overlap compared to those with an 
overlap (12). In addition, Moscone et al. studied this practice in 57 women who breastfed 
during pregnancy, with 43% overlapping until delivery and reported that the average birth 
weight in this group was normal (3.43 Kg) (18).  
These previously published studies together with the present results showing a more 
than two-fold greater proportion of mothers who breastfed during late pregnancy among the 
controls compared to the cases, suggest that there are maternal physiological adaptations that 
enable adequate fetal growth (19). More research is needed to understand these physiological 
adaptations and their effect on maternal body stores.  
We found differences between SGA cases and their controls on some important 
maternal characteristics, including maternal height, weight gain during pregnancy and 
previous children’s birth weights.  These results are consistent with reported risk factors 
associated with low birth weight (20-23).   Analysis of interactions involving factors that 
may modify the effect of a breastfeeding-pregnancy overlap on the risk of SGA was not 
feasible due to the limited sample size.   
We did not find a significant difference in maternal hair zinc concentrations between 
SGA cases and controls. This finding is in contrast to previous studies (24-26), that used 
other indicators to evaluate maternal zinc status (including serum, plasma and leucocytes). 
The inconsistent result with other studies could be due to 1) the use of a different biological 
indicator; 2) the small sample size and wide range of zinc hair concentrations that limited our 
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ability to capture differences between the SGA cases and controls; and 3) changes in zinc 
homeostasis such as increase on fractional zinc absorption and intestinal conservation, which 
occur in lactating as well as pregnant women (27-29).   
Conclusion 
In conclusion, in our population an overlap of breastfeeding during late pregnancy did 
not represent a risk for SGA.  However, health professionals should be cautious about 
recommending this practice as negative postnatal consequences have been associated with 
this practice. More longitudinal research is recommended in this area, to understand the 
maternal physiological adaptations behind the practice of breastfeeding during pregnancy and 
to further explore its short as well as long-term postnatal consequences. 
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Figure 1. Flow of participants enrollment showing detailed numbers of subjects who met and 
did not met the general as well as the specific case-control criteria. 1 Some mothers did not 
meet more than one general criteria, therefore the sum is > 18946. 
 923 possible controls  
        without cases 
   41 possible cases not enrolled  
        before end of enrollment 
        period   
   25 miscellaneous 
   
Deliveries screened  
n =21,534 
Met general inclusion criteria N      
n =2,587 
 
Ineligible  
n =18,946 
 
  9,241 primiparous             1 
  5,126 last child > 4 y 
  1,309 mother < 18 y 
     274 multiple pregnancy 
  1,361 labor did not start 
            spontaneously 
  1,600 multigravida nulliparous 
  3,396 miscellaneous  
 Met criteria for cases or controls 
n =1,250 
Not invited 
n = 989  
Without controls 
n = 17 
  7 refused  
  2 annulled  
  7 refused  
    
Controls analyzed 
n = 150 
Cases analyzed 
n = 78 
Controls invited 
n = 159 
Cases invited 
n = 102 
Cases accepted 
n = 95 
Controls accepted 
n = 150 
Zinc cases 
n = 44 
Zinc controls  
n = 30 
Cases analyzed 
n = 30 
Controls analyzed 
n = 30 
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Table 1. Maternal sociodemographic characteristics by presence of SGA  
SGA Non-SGA 
p† n = 78 n = 150 
      n (%) n (%) 
Age, y * 26.2 + 5.9 27.8 + 6.0 0.046 
Place of birth 0.264 
Lima City 35 (44.9) 81 (54.0) 
Lima (mountain) 14 (5.1) 2 (1.3) 
Coast 8 (10.3) 16 (10.7) 
Mountain 23 (29.5) 43 (28.7) 
Rainforest 7 (8.9) 7 (4.7) 
Other 1 (1.3) 0 (0.0) 
Unknown 0 (0.0) 1 (0.6) 
Time living in Lima, y * 17.7 + 12.1 19.8 + 12.2 0.214 
Educational status 0.246 
Not completed elementary school 5 (6.4) 10 (6.7) 
Completed elementary school 6 (7.7) 10 (6.7) 
Not completed high school 23 (29.5) 37 (24.7) 
Completed high school 30 (38.5) 68 (45.3) 
Not completed technical college 9 (11.5) 5 (3.3) 
Completed technical college   3 (3.8) 14 (9.3) 
Not completed college 1 (1.3) 3 (2.0) 
Completed college   1 (1.3) 3 (2.0) 
Marital Status 0.042 
Married 10 (12.8) 40 (26.7) 
Live together 58 (74.4) 98 (65.3) 
Single 9 (11.5) 8 (5.3) 
Divorced 0 (0.0) 0 (0.0) 
Separated 1 (1.3) 4 (2.7) 
Working status 0.497 
Yes 13 (16.7) 20 (13.3) 
No     65 (83.3) 130 (86.7)   
*
 
 mean + SD 
    
  
†
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for    
  the comparison of means with the matched case-controls treated as blocks. 
  SGA:  small for gestational age, < 10th percentile birth weight   
  Non-SGA: 50th percentile > birth weight < 90th 
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Table 2. Household characteristics of SGA cases and their controls  
    SGA Non-SGA 
p* n = 78 n = 150 
    n (%) n (%) 
Housing 0.358 
Own 7 (9.0) 25 (16.7) 
Rented 25 (30.1) 39 (26.0) 
Relative's 44 (56.4) 80 (53.3) 
Other 2 (2.5) 6 (4.0) 
Housing main material 0.580 
Bricks and cement 52 (66.7) 107 (71.4) 
Bricks 0 (0.0) 2 (1.3) 
Wood 14 (17.9) 27 (18.0) 
Straw mats 4 (5.1) 5 (3.3) 
Others 8 (10.3) 9 (6.0) 
Housing source of light 0.552 
House connection 62 (79.5) 128 (85.3) 
Neighbors 14 (17.9) 18 (12.0) 
Lamp 0 (0.0) 1 (0.7) 
Candles 2 (2.6) 3 (2.0) 
Housing source of water 0.791 
Potable water 62 (79.5) 115 (76.7) 
Public sink 3 (3.9) 3 (2.0) 
Tanker 10 (12.8) 23 (15.3) 
Neighbors 3 (3.8) 8 (5.3) 
Well 0 (0.0) 1 (0.7) 
Housing fuel used for cooking 0.213 
Gas 60 (76.9) 125 (83.4) 
Kerosene 8 (10.3) 18 (12.0) 
Electricity 1 (1.3) 0 (0.0) 
Wood 6 (7.7) 5 (3.3) 
Others 3 (3.8) 2 (1.3) 
Place used as a bathroom 0.791 
Toilet 59 (75.6) 118 (78.7) 
Outhouse with drain 2 (2.6) 4 (2.7) 
Outhouse without drain 12 (15.4) 23 (15.3) 
Open land 3 (3.8) 4 (2.7) 
Others   2 (2.6) 1  (0.6)   
* Pearson X2 was used for testing significant difference of proportions. 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 3. Maternal practice of breastfeeding during pregnancy by presence of SGA 
        SGA      Non-SGA 
    n = 78         n = 150 
        n (%)           n (%) 
Breastfeeding during late pregnancy  
 Yes   3  (3.8)        14  (9.3) 
 No   75  (96.2)      136  (90.7) 
    
  
    Odds Ratio  95% CI* 
    Lower Upper 
    
 
  
Risk of breastfeeding during late 
pregnancy on the occurrence of SGA 0.41 0.11 1.47 
* Conditional logistic regression 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
 
 
 
 
Table 4. Maternal exposure to recommendations regarding breastfeeding 
during pregnancy by presence of SGA 
      
        SGA   Non-SGA 
p†        n = 78   n = 150 
             n (%)   n (%) 
From a health professional 0.468 
Yes 13 (16.7) 31 (20.7) 
No 65 (83.3) 119 (79.3) 
From a relative 0.000 
Yes 12 (15.4) 61 (40.7) 
No 66 (84.6) 89 (59.3) 
From a friend 
Yes 13 (16.7) 26 (17.3) 0.899 
No 65 (83.3) 124 (82.7) 
* mean + SD 
     
  
†
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted  
  for the comparison of means with the matched case-controls treated as blocks.   
  SGA:  small for gestational age, < 10th percentile birth weight   
  Non-SGA: 50th percentile > birth weight < 90th 
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Table 5.  Newborn characteristics of  SGA cases and their controls 
SGA Non-SGA 
P* n = 78 n = 150 
      n (%) n (%) 
Newborn's sex 0.001 
Masculine 26 (33.3) 84 (56.0) 
Feminine 52 (66.7) 66 (44.0) 
Newborn's weight, g 2529.1 + 173.9 3534.2 + 175.5 0.000 
Newborn's length, cm 46.9 + 1.4 50.5 + 1.4 0.000 
Newborn's Apgar scores 
1 minute 8.0 + 1.0 8.1 + 1.0 0.497 
5 minutes 8.9 + 0.5 9.0 + 0.5 0.402 
Newborn in incubator 0.194 
Yes  4 (5.1) 3 (2.0) 
No 74 (94.9) 147 (98.0) 
Newborn pathology 0.168 
Yes  5 (6.4) 4 (2.7) 
No 73 (93.6) 146 (97.3) 
Newborn use of oxygen 0.145 
Yes 6 (7.7) 5 (3.3) 
No     72 (92.3) 145 (96.7)   
* Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks. 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 6. Maternal health behavior during current pregnancy by presence of SGA  
      SGA        Non-SGA 
p*      n = 78          n = 150 
           n  (%)           n  (%) 
Use of medicines 
Antibiotics 0.524 
Yes 25 (32.0) 42 (28.0) 
No 53 (68.0) 102 (72.0) 
Vaginal suppositories 0.200 
Yes 22 (28.2) 55 (36.7) 
No 56 (71.8) 95 (63.3) 
Smoking 0.194 
Yes 4 (5.1) 3 (2.0) 
No 74 (94.8) 147 (98.0) 
Passive smoking 0.197 
Yes 13 (16.7) 16 (10.7) 
No 65 (83.3) 134 (89.3) 
Supplement use 0.461 
Yes 66 (84.6) 121 (80.7) 
No 12 (15.4) 29 (19.3) 
   Zinc 0.402 
   Yes 14 (17.9) 34 (22.7) 
   No  64 (82.1) 114 (76.0) 
   Unknown 0 (0.0) 2 (1.3) 
   Iron 0.512 
   Yes 64 (82.1) 117 (78.0) 
   No 14 (17.9) 31 (20.7) 
   Unknown 0 (0.0) 2 (1.3) 
   Calcium 0.566 
   Yes 22 (28.2) 39 (26.0) 
   No 56 (71.8) 109 (72.7) 
   Unknown 0 (0.0) 2 (1.3) 
   Folic Acid 0.108 
   Yes  21 (26.9) 58 (38.7) 
   No 57 (73.1) 90 (60.0) 
   Unknown   0 (0.0) 2 (1.3)   
* Pearson X2 was used for testing significant difference of proportions. 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 7. Maternal antecedents and health characteristics by presence of SGA 
    SGA    Non-SGA 
P **    n = 78      n = 150 
      mean + SD   mean + SD 
Last child's age, mo    29.3 + 3.3    29.0 + 3.3 0.567 
Last child's birth weight, g * 2859.7 + 526.6     3309.3 + 531.3   0.000 
Last child's sex†   0.196 
Masculine   45  (57.7) 73  (48.7) 
Feminine   33  (42.3)      77   (51.3) 
Last child’s age when weaned, mo ‡ 14.3 + 7.2         16.5 + 7.3   0.033 
Number of pregnancies, # 2.0 + 1.5         2.4 + 1.5   0.088 
Number of deliveries, # 1.8 + 1.3         2.0 + 1.3   0.256 
Weight gained during pregnancy, kg §   8.6 + 5.2        11.7 + 5.0   0.004 
Maternal height, cm ║ 151.8 + 6.2    154.2 + 6.2 0.007 
Maternal hemoglobin, g/dL ¶ 11.0 + 1.2        11.2 + 1.2   0.177 
Maternal preeclampsia†   0.124 
Yes     7   (9.0)         6   (4.0) 
No       71   (91.0)     144   (96.0)   
* cases n = 70 controls n = 139 
†
 n (%) cases 
‡
cases n = 76 controls n = 139 ( 2 cases and 11 controls breastfed until delivery) 
§
 cases = 42 controls = 87 
║ cases n = 77 controls = 146 
¶ cases n = 62   controls n = 134; Hb values available were from different trimesters: cases (1st = 0%, 2nd = 
27.4%, 3rd = 72.6%) controls (1st = 9%, 2nd = 29.8%, 3rd = 61.2%) 
** Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks 
SGA:  small for gestational age, < 10th percentile birth weight   
 Non-SGA: 50th percentile > birth weight < 90th 
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CHAPTER 5: THE OVERLAP OF BREASTFEEDING DURING LATE 
PREGNANCY IS NOT ASSOCIATED WITH PROLONGED ACTIVE PHASE OF 
LABOR AMONG PERUVIAN WOMEN 
 
A paper to be submitted to The Journal of American Clinical Nutrition 
Rossina G. Pareja1, Grace S. Marquis2, Mary Penny3 
 
 
Abstract 
 
Background The practice of breastfeeding during pregnancy has been reported in 
developing as well as developed countries. This practice implies a dual physiological stress 
that may affect maternal nutritional status and pregnancy outcomes.  
Objective We hypothesized that the practice of breastfeeding until late pregnancy would be 
associated with an increased risk of experiencing a prolonged active phase of labor (PAPL) 
and mothers with PAPL would have a lower zinc status than mothers with normal 
progression of labor.  
Design A case-control study was designed and two matched controls (n = 345) for each case 
(n = 176) were enrolled. In addition, we had a nested case-control study designed with one 
control (n = 32) matched to one case (n = 32) for the analysis of maternal hair as an indicator 
of zinc status.  
Results There was no group difference in the proportion of mothers who breastfed during 
late pregnancy (7.95% of cases and 7.83% of controls); the odds ratio was 1.02 (95% CI= 
0.51, 2.04) for breastfeeding during late pregnancy with the occurrence of PAPL. In addition,  
_________________ 
1
 Department of Food Science and Human Nutrition, Iowa State University, USA. 
2
 School of Dietetics and Human Nutrition, McGill University, Canada. 
3  Instituto de Investigación Nutricional, Peru. 
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no difference between PAPL cases and the controls was found for maternal hair zinc 
concentrations (165.94 + 36.14 µg/g  in cases and 155.75 + 36.14 µg/g  in controls;                
p = 0.268). 
Conclusion Our findings do not support the hypothesis that the practice of breastfeeding 
during late pregnancy represents a risk for prolonged active phase of labor. More research on 
other birth and postnatal outcomes are needed to fully understand any potential risks 
associated with this practice. 
___________________ 
Key words:  breastfeeding, pregnancy, prolonged active phase of labor. 
 
 
Introduction  
 
It is estimated that 529,000 women die annually from causes related to complications 
during pregnancy, labor, childbirth, and the postpartum period (1). Two of the most common 
causes of maternal death, hemorrhaging and sepsis, are often associated with complications 
during labor. Prevention of labor complications or early detection with adequate management 
will reduce maternal mortality; therefore, understanding the factors that relate to labor 
complications is a maternal health priority.  
 The association between maternal nutritional status and labor complications has been 
reported previously (2). For example, anemia has been linked to prolonged labor (3).  
Experimental animal studies have reported prolonged labor in rats on a zinc-deficient diet 
compared to those on a normal diet (4). In addition, observational studies of women have 
shown associations between plasma zinc levels and the duration of the active period of 
delivery (5, 6).  
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Several studies have examined the adjustments of zinc homeostasis that occur in 
pregnant or lactating women in response to the additional demands of these physiological 
stages (7-9).  However, there is a dearth of information on the physiological implications of 
breastfeeding during late pregnancy, when a woman would be exposed to a double 
physiological stress; which is of concern due to the high rates of micronutrient deficiencies  
as well as deficient nutrient intake frequently reported among pregnant and lactating women 
in developing countries (10,11) as well as in developed countries, like the United States 
where only 52% of lactating women and 59% of pregnant women have an adequate zinc 
intake (12). It is estimated that worldwide 82% of pregnant women have inadequate zinc 
intakes (13).   
           While many mothers wean their children when they become pregnant again, other 
mothers chose to continue breastfeeding for part or all of the pregnancy. This practice has 
been reported not only in developing countries (14, 15) but also in the United States (12). In 
Peru, a recent study reported that 10% of the women with a child less than 4 years old 
breastfed during the last trimester of pregnancy (16). According to Moscone and Monroe the 
most common reason to continue breastfeeding that was given by mothers was the security 
and comfort of the nursing child (17).   
We hypothesized that the practice of breastfeeding through late pregnancy would 
increase the risk of having a prolonged active phase of labor (PAPL) and that maternal zinc 
status among mothers with a PAPL would be lower than maternal zinc status among mothers 
with a normal active phase of labor.  
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Subjects and methods  
Study site 
The study was conducted at three government hospitals in Lima, Peru: Maria 
Auxiliadora Hospital (southern Lima), San Bartolome Mother-Child National Teaching 
Hospital (north-central Lima), and Hipolito Unanue Hospital (east-central Lima).  The 
hospitals were chosen because each had a high rate of attended births and an overlap of 
breastfeeding during late pregnancy was common among prenatal clinic clients.  
Study design 
This was a case-control study designed to have two matched controls for each case. In 
addition, we had a nested case-control study designed to have one control matched to one 
case for the analysis of maternal zinc status. 
Ethical approval  
The study was reviewed and received the ethical approval from the Institutional 
Review Board of Iowa State University and the ethical committees from the Instituto de 
Investigacion Nutricional (IIN) and the three hospitals where the study was conducted.  
Subjects 
The participants were mothers > 18 years old who gave birth at any of the three 
hospitals and met the inclusion criteria for the study:  
1) labor started spontaneously with cephalic presentation; 
2) newborn was a single, live birth;  
3) newborn had a sibling <4 y of age, lived with the family, and was breastfed at birth; and   
4) mother was without a diagnosis of mechanic dystocia (e.i. small pelvis for birth size). 
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Definition of cases and controls A case was defined as a mother with a cervical dilatation 
curve that crossed the alert line to the right on the partograph. The partograph used by the 
three hospitals to control progression of labor was developed by the Centro Latinoamericano 
de Perinatología y Desarrollo Humano (CLAP) (Latin-American Center of Perinatology and 
Human Development) (18). 
A control for PAPL was defined as a mother with a cervical dilatation curve that did 
not cross the alert line on the partograph and did not receiving any drug intervention to 
improve the progress of dilatation. Controls were matched to cases according to the initial 
examination of cervical dilatation:, the initial report of cervical dilatation of the control had 
to be at least at the same initial dilatation reported on the case (e.g., if the initial point on the 
partograph curve for the case was 5 cm of dilatation, then the control had to have the initial 
point at not higher than 5 cm of dilatation). In addition, controls were matched by hospital of 
delivery and interpregnancy intervals (9 - 21 months, 22 – 34 months, and 35 – 47 months). 
 
Data collection 
Each hospital was visited by a trained health professional who screened the births 
daily. To be able to match the controls to their respective cases, the health professional 
identified the case first. Mothers were approached for enrollment at least 6 hours after 
delivery. Participants were interviewed about their sociodemographic characteristics, 
breastfeeding-lactation overlap practice and food frequency intake during pregnancy. After 
the interview, the health professional reviewed the mother’s and newborn’s clinical chart to 
extract information regarding obstetrical records, prenatal control, labor characteristics, 
newborn’s birth weight, length, and Apgar score. A subsample of women provided hair 
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samples for zinc analysis. The hair samples were collected from the occipital region, as close 
as possible to the scalp using stainless steel scissors. For the analysis, the proximal 2.0 cm 
(cut in a < 1cm length pieces) were retained in a small polyethylene bottle. Hair samples 
were taken, at ambient temperature, to the laboratory for the analysis by atomic absorption 
spectrophotometry (19). A certified reference material (hair) from the National Institute for 
Environmental Studies (certified reference material No 13, Tsukuba, Ibaraki) was used in 
each batch analysis, for quality control.  
Data analysis 
Comparisons between PAPL cases and controls for continuous variables were made 
using analysis of variance with the matched case-controls treated as blocks. Comparisons 
between cases and controls for categorical variables were made using Pearson 2. A 
conditional logistical regression was used to examine the risk of breastfeeding during late 
pregnancy associated with the occurrence of PAPL. The analyses were conducted using 
SYSTAT version 9.0 (SPSS, Chicago, IL). 
Results 
Study participants 
Between March 2006 and April 2007 a total of 21,534 deliveries were screened 
(Figure 1), of whom 2,587 mothers met the general inclusion criteria, and 1,175 met the 
criteria as cases or controls.  A total of 550 mothers were invited to participate; 18 women 
refused (4 cases and 14 controls). Most of the women who met the inclusion criteria but did 
not participate in the study were women who were not randomly selected as controls. Four 
mothers who accepted to participate were not included in the study because of inconsistent 
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information on the clinical chart (n=2) and intervention with oxytocin during labor (n = 2). A 
total of 183 cases and 345 controls were enrolled. 
From the 183 cases of PAPL 7 were excluded from the analysis due to the lack of 
matched controls. A total of 176 cases and 345 controls were included in the analysis. 
A subsample of 65 women provided hair samples for zinc analysis. One cases was 
excluded due to the lack of a matched control, thus the maternal hair zinc concentration of 32 
cases and 32 controls were analyzed. 
Maternal sociodemographic characteristics 
PAPL cases did not differ from controls in maternal sociodemographic or housing 
characteristics, with the exception of maternal work (Table 1).  A higher proportion of PAPL 
mothers worked until delivery as compared to the cases (p < 0.05).  
Maternal breastfeeding practices during late pregnancy 
A total of 38.2% of mothers reported that they breastfed during the current 
pregnancy; 16.3% of the women continued breastfeeding during the second trimester and 
7.9% still continued during the third trimester. A similar proportion of PAPL and control 
mothers breastfed during late pregnancy (7.95% and 7.83%, respectively) (Table 2); the 
average frequency of breastfeeding episodes per day was similar between cases and controls 
(3.4 + 1.9 vs. 3.0 + 2.1). An odds ratio of around one was found for the risk of breastfeeding 
during late pregnancy with the occurrence of PAPL.   
There were no differences between cases and controls on maternal exposure to 
recommendations regarding breastfeeding during pregnancy (Table 3).    
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Maternal health antecedents  
No differences were found between cases and controls regarding maternal practices 
during the current pregnancy such as use of medicines, smoking or supplement use (Table 
4). 
Mothers in both groups showed similar anthropometric as well as obstetric 
characteristics (Table 5). Although not reaching significance in this study, PAPL may be 
associated with having had a previous cesarean section (27.7 % PAPL cases vs. 20.6 % 
controls; p = 0.114).  
Obstetrics procedures during labor 
There was no difference in the proportion of mothers who arrived at the hospital with 
a spontaneous rupture of membranes (Table 6), but a difference was found in the proportion 
of mothers who experienced an artificial rupture during labor. Around 56% of the mothers in 
the control group remained with intact membranes until the delivery of the baby. Oxytocin 
was used on 34.7% PAPL mothers. In addition, nine deliveries (5.1%) in the case group 
ended in cesarean section. Although there was a tendency for a higher proportion of 
episiotomies to be performed on PAPL mothers (16% cases vs. 15.4% controls, p = 0.054), 
there was still a significantly higher proportion of mothers in this group who presented tears 
(40.91% cases vs. 30.14% controls; p = 0.014). 
Newborn characteristics 
There were significant group differences in newborn anthropometric measures, 
including birth weight (p = 0.001) (Table 7); newborns in the PAPL group were around two 
days older and were smaller than the controls (p < 0.020). There were no differences between 
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the groups regarding Apgar scores or medical interventions at birth, such as use of oxygen or 
an incubator.  
Maternal food frequency intake 
Food intake was similar between groups with only one exception.  PAPL mothers 
reported consuming fish on average one time more per month (6.94 times PAPL vs. 5.97 
controls; p = 0.016).  There was a wide range of values for monthly food frequency intakes 
on most of foods (data not shown). 
Maternal zinc status  
No group differences were found in maternal hair zinc concentrations. PAPL cases 
had on average 165.94 + 36.14 µg/g and the controls had 155.75 + 36.14 µg/g (p = 0.268). 
The zinc concentration of the certified reference material, used to control the quality 
of the analysis, was 172 + 11 µg/g (National Institute for Environmental Studies ) and the 
mean value obtained in our laboratory was 170.0 + 3.2 µg/g. 
Discussion   
Contrary to what we hypothesized, breastfed during late pregnancy was not 
associated with an increase in the active phase of labor.  To our knowledge this is the first 
study designed to examine the association between the practice of breastfeeding during 
pregnancy and the occurrence of a prolonged active phase of labor. Our results are not 
consistent with Marquis et al. previous work where they reported a higher incidence of 
dystocic labor among mothers who overlapped breastfeeding during late pregnancy 
compared to mothers who did not breastfeed at all during their pregnancy (16). The 
inconsistent results may be due in part to the inclusion of both mothers with dystocic labor 
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due to mechanical problems (i.e., cephalopelvic disproportion) as well as mothers who had a 
dystocic labor due to a delay on cervical dilatation, the outcome examined in the present 
study.  In addition, the absence of an association could be due to a minimal nutritional stress 
of the feeding practice as both the case and control mothers reported a low frequency of 
breastfeeding events per day during late pregnancy.  
 Around 8% of our study population reported the practice of breastfeeding during late 
pregnancy which although it is 20% less than what Marquis et al. reported in their Lima 
sample (16), it is a substantial number of pregnant women.  Our study mothers came from 
many different districts of Lima while the previous study enrolled mothers living in only 
from one district, suggesting that breastfeeding practices vary by mothers’ regional 
backgrounds, economic status, or other cultural factors.  
 Unlike previous reports (5, 6, 20), we did not find significant differences in maternal 
hair zinc concentrations between the PAPL cases and their controls.   In earlier studies of 
PAPL, zinc concentrations were evaluated using maternal plasma or serum. Hair can be 
considered as a long-term indicator of zinc status.  Any difference in maternal zinc status 
between our PAPL cases and their controls that occurred close to the delivery date, would not 
be detectable in our hair samples.  
Birth weight and gestational age have been reported to influence dilatation curves 
(21), so we are not sure if this could have influenced our classification of cases and controls 
since small statistical significant differences were found between these two groups on birth 
weight and gestational age. Since we relayed the diagnosis of a case or control on reports 
made by the hospitals’ health professionals, we tried to minimize possible bias by matching 
cases and controls by hospitals. 
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In conclusion, our findings do not support the hypothesis that the practice of 
breastfeeding during late pregnancy represents a risk for a prolonged active phase of labor.  
Given that the practice of breastfeeding during late pregnancy is still occurring frequently, 
additional research is needed to determine the consequences, if any, for the mother and 
infant.  Health professionals need evidence-based recommendations to optimize maternal and 
child health. 
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Figure 1. Flow of participants enrollment showing detailed numbers of subjects who met and 
did not met the general as well as the specific case-control criteria. 1 Some mothers did not 
meet more than one general criteria, therefore the sum is > 18946. 
Without controls 
n = 7 
 520 possible controls  
        without cases 
   19 possible cases not enrolled  
        before end of enrollment 
        period    
   86 miscellaneous 
   
Deliveries screened  
n =21,534 
Met general inclusion criteria       
n =2,587 
 
Ineligible  
n =18,946 
 
  9,241 primiparous             1 
  5,126 last child > 4 y 
  1,309 mother < 18 y 
     274 multiple pregnancy 
  1,361 labor did not start 
            spontaneously 
  1,600 multigravida nulliparous 
  3,396 miscellaneous  
 Met criteria for cases or controls 
n =1,175 
Not invited 
n = 625  
 14 refused  
  2 annulled  
  4 refused  
  2 annulled  
Controls analyzed 
n = 345 
Cases analyzed 
n = 176 
Controls invited 
n = 361  
Cases invited 
n = 189 
Cases accepted 
n = 183 
Controls accepted 
n = 345 
Zinc cases 
n = 33 
Zinc controls  
n = 32 
Cases analyzed 
n = 32 
Controls analyzed 
n = 32 
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Table 1. Maternal sociodemographic characteristics by presence of PAPL 
      
       PAPL     Non-PAPL 
p 2       n = 176       n = 345 
             n  (%)        n  (%) 
Age, y 1   27.0 + 5.2   27.7 + 5.2 0.151 
Place of birth 0.911 
Lima 98 (55.7) 183 (53.0) 
Lima province 6 (3.4) 9 (2.6) 
Coast 15 (8.5) 32 (9.3) 
Mountain 48 (27.3) 988 (28.4) 
Rainforest 9 (5.1) 23 (6.7) 
Time living in Lima, y 1   19.9 + 9.8   19.8 + 9.8 0.923 
Educational status 0.143 
Illiterate 0 (0.0) 1 (0.3) 
Not completed elementary school 14 (8.0) 17 (4.9) 
Completed elementary school 6 (3.4) 20 (5.8) 
Not completed high school 32 (18.2) 88 (25.5) 
Completed high school 95 (54.0) 161 (46.7) 
Not completed technical college 13 (7.4) 16 (4.7) 
Completed technical college  9 (5.1) 28 (8.1) 
Not completed college 5 (2.8) 6 (1.7) 
Completed college  2 (1.1) 8 (2.3) 
Marital Status 0.975 
Married 41 (23.3) 78 (22.6) 
Live together 126 (71.6) 246 (71.3) 
Single 6 (3.4) 14 (4.1) 
Separated 3 (1.7) 7 (2.0) 
Working status until delivery 0.047 
Yes 34 (19.3) 44 (12.7) 
No 142 (80.7) 301 (87.3) 
Housing 0.199 
Own 18 (10.2) 45 (13.1) 
Rented 39 (22.2) 99 (28.7) 
Relative's 114 (64.8) 195 (56.5) 
Other     5 (2.8) 6 (1.7)   
1 
 mean + SD 
    
 2
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for    
the comparison of means with the matched case-controls treated as blocks. 
PAPL: prolonged active phase of labor 
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Table 2. Maternal breastfeeding practices by presence of  PAPL 
        PAPL  Non-PAPL 
    n = 176 n = 345 
        n (%) n (%) 
Breastfeeding during late pregnancy 14  (7.9) 27  (7.8) 
    162  (92.1) 318  (92.2) 
       
    Odds Ratio 95 % CI
1 
    Lower Upper 
    
 
  
Risk of breastfeeding during late pregnancy 
on the occurrence of PAPL 1.02 0.51 2.04 
1
 Conditional logistic regression conducted  for the Odds Ratio 
PAPL: prolonged active phase of labor 
 
  
  
 
Table 3. Maternal breastfeeding antecedents by presence of PAPL 
      PAPL  Non-PAPL 
P 3 n = 176 n = 345 
      n (%) n (%) 
Maternal contact with recommendations about breastfeeding during pregnancy 
From a health professional 0.361 
Yes 32 (18.2) 52 (15.1) 
No 144 (81.8) 293 (84.9) 
From a relative 0.675 
Yes 65 (36.9) 121 (35.1) 
No 111 (63.1) 224 (64.9) 
From a friend 0.152 
Yes 23 (13.1) 62 (18.0) 
No 153 (86.9) 283 (82.0) 
Last child's age when 
weaned, mo 1,2  16.3 + 7.5 15.8 + 7.4 0.460 
1 mean + SD 
2 cases n = 165 controls n = 325 
3
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks. 
PAPL: prolonged active phase of labor 
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Table 4. Maternal health behavior during current pregnancy by presence  
of PAP L 
      
       PAPL  
    Non-
PAPL 
P  1 
       n = 176     n = 345 
            n  (%)     n  (%) 
Use of medicines     
Antibiotics 0.415 
Yes 55 (31.2) 96 (27.8) 
No 121 (68.8) 249 (72.2) 
Vaginal suppositories 0.541 
Yes 55 (31.2) 117 (33.9) 
No 121 (68.8) 228 (66.1) 
Smoking 0.512 
Yes 7 (4.0) 10 (2.9) 
No 169 (96.0) 335 (97.1) 
Passive smoking 0.718 
Yes 21 (11.9) 45 (13.0) 
No 155 (88.1) 300 (87.0) 
Use of supplements  0.596 
Yes 153 (86.9) 294 (85.2) 
No 23 (13.1) 51 (14.8) 
    Zinc 0.534 
    Yes 43 (24.5) 73 (21.1) 
    No 131 (74.4) 270 (78.3) 
    Unknown 2 (1.1) 2 (0.6) 
    Iron 0.300 
    Yes 151 (85.8) 290 (84.1) 
    No 24 (13.6) 55 (15.9) 
    Unknown 1 (0.6) 0 (0.0) 
    Calcium 0.484 
    Yes 56 (31.8) 96 (27.8) 
    No 118 (67.1) 247 (71.6) 
    Unknown 2 (1.1) 2 (0.6) 
    Folic Acid 0.734 
    Yes 72 (40.9) 136 (39.4) 
    No 102 (58.0) 207 (60.0) 
    Unknown   2 (1.1) 2 (0.6)   
1
 Pearson X2 was used for testing significant difference of proportions 
PAPL: prolonged active phase of labor 
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Table 5. Maternal antecedents and health characteristics by presence of PAPL 
        PAPL  Non-PAPL 
P 5     n = 176 n = 345 
        mean + SD mean + SD 
Last child's age, mo    30.6 + 3.6        30.9 + 3.7 0.440 
Number of pregnancies, #    2.0 + 1.3     2.2 + 1.3 0.037 
Number of deliveries, #    1.7 + 1.1     1.9 + 1.1 0.127 
Weight gained during pregnancy, kg 1 11.1 + 4.3        11.3 + 4.2 0.726 
Maternal height, cm 2     153.4 + 5.6      154.2 + 5.6  0.114 
Maternal hemoglobin, g/dL 3 11.1 + 1.3         11.2 + 1.3 0.246 
Maternal preeclampsia 4    0.970 
Yes      5  (2.8) 10  (2.9)  
No    171  (97.2) 335  (97.1)  
Maternal previous cesarean 4   0.114 
Yes      47  (27.7)   71  (20.6)  
No       129   (73.3) 274  (79.4)   
1 cases n = 111 controls n = 219 
    
2 cases n = 174 controls n = 340 
    
3 cases n = 156 controls n = 313; Hb values available were from different trimesters: cases (1st = 6.4%, 2nd 
= 30.8%, 3rd = 62.8%) controls (1st = 4.8%, 2nd = 27.5%, 3rd = 67.7%) 
4 n (%) 
5
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for 
the comparison of means with the matched case-controls treated as blocks. 
  PAPL: prolonged active phase of labor 
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Table 6. Obstetrics procedures during labor by presence of PAPL 
        PAPL  Non-PAPL 
P 2 n = 176 n =  345 
        n (%) n (%) 
Maternal membranes at the first clinical report 
Intact 154 (87.5) 289 (83.8) 0.259 
Broken 22 (12.5) 56 (16.2) 
Maternal membranes during labor 
Artificial rupture 85 (48.3) 38 (11.0) 0.000 
Intact until last cm of dilatation 38 (21.6) 194 (56.3) 
Spontaneously broken 50 (28.4) 105 (30.4) 
Broken but unknown artificial or spontaneous 3 (1.7) 8 (2.3) 
Use of oxytocin in cases 
Yes 61 (34.7) 0 (0.0) 
No 115 (65.3) 345 (100) 
Use of forceps 0.987 
Yes 1 (0.6) 2 (0.6) 
No 175 (99.4) 343 (99.4) 
Delivery ended in cesarean 0.000 
Yes 9 (5.1) 0 (0.0) 
No 167 (94.9) 345 (100) 
Maternal episiotomy 0.054 
Yes 39 (22.2) 53 (15.4) 
No 137 (77.8) 292 (84.6) 
Maternal tears 0.014 
Yes 72 (40.9) 104 (30.1) 
No 104 (59.1) 241 (69.9) 
Maternal examinations at hospital, # 1 9.9 + 3.1 5.6 + 3.1 0.000 
1
 mean + SD, number of examinations at the hospital during labor. 
2
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks. 
PAPL: prolonged active phase of labor 
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Table 7. Newborn characteristics of  PAPL cases and their controls 
        PAPL  Non-PAPL 
P 2 n = 176 n = 345 
        n (%) n (%) 
Newborn's sex 0.061 
Masculine 102 (58) 170 (49.3) 
Feminine 74 (42.0) 175 (50.7) 
Newborn's weight, g 1 3416.8 + 388.6 3299.2 + 390.6 0.001 
Newborn's length, cm 1     50.5 + 2.2 50.0 + 2.3 0.014 
Newborn's gestational age, wk 1     39.2 + 1.3 38.9 + 1.3 0.020 
Newborn's apgar 
1 minute       8.1 + 0.7 8.1 + 0.7 0.203 
5 minutes       9.0 + 0.3 9.0 + 0.3 0.581 
Newborn in incubator 0.559 
Yes 5 (2.8) 7 (2.0) 
No 171 (97.2) 338 (98.0) 
Newborn pathology 0.906 
Yes 7 (4.0) 13 (3.8) 
No 169 (96.0) 332 (96.2) 
Newborn use of oxygen 0.965 
Yes 7 (4.0) 14 (4.1) 
No       169 (96.0) 331 (95.9)   
1 mean + SD 
     
2
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks. 
PAPL: prolonged active phase of labor 
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CHAPTER 6: GENERAL CONCLUSIONS 
The findings in the population studied demonstrate that the practice of breastfeeding 
during late pregnancy does not represent a risk for having a small for gestational age baby or 
experiencing a prolonged active phase of labor. Maternal physiological adaptations may 
occur to compensate for the extra physiological stress that this practice represents for the 
mother.  More research is needed to examine these adaptations and the possible short-term as 
well as long-term implications of the adaptations on maternal, toddler, and infant health.  
No correlation between zinc concentration in plasma and zinc concentration in hair 
was found (data shown in appendix A). This absence of an association suggests that hair zinc 
concentrations may be a poor indicator of maternal nutritional status and could explain the 
non-significant results we found when we compared maternal hair zinc concentrations 
between cases and controls of small-for-gestational age and prolonged active phase of labor.  
Previous studies that reported an association between maternal zinc status and these birth 
outcomes used mainly plasma or serum as an indicator of zinc status.   
To our knowledge this is the first study that has examined birth outcomes such as 
small-for-gestational age and prolonged active phase of labor, in association to the practice of 
breastfeeding during late pregnancy.  Recommendations for health professionals require 
confirmatory studies before drawing conclusions about birth risks associated with this 
practice.  
Recommendations for future research 
Future studies that involve collecting information from clinical charts should consider 
employing trained health professionals to work in the hospitals and report the information 
82 
 
needed on the clinical charts.  In the present study we relied on the clinical information 
collected by the hospitals’ own health professionals and we had to exclude the enrollment of 
some participants due to the lack of consistent information on the clinical charts.  
Longitudinal studies are recommended for a more in-depth study of the practice of 
breastfeeding during pregnancy since a better understanding of maternal physiological 
adaptations to this practice and its possible consequences is required.  Moreover, since we 
have shown that this practice is still frequent among pregnant women, health professionals 
need to be prepared with evidence-based recommendations for women who choose to 
continue breastfeeding during their pregnancy. 
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APPENDIX A. ADDITIONAL TABLES 
 
Table 1.  Maternal hair zinc concentration by the presence of BDP 
 
     
  BDP  Non-BDP 
p* 
 
 
n = 23 n = 23 
 
  mean + SD mean + SD 
 
   
 
 Maternal zinc in hair  
(ug/g)     160.57 + 29.42   162.13 + 29.42 0.858  
        
 
* ANOVA was conducted for continue variables with the matched case-controls treated as blocks 
  BDP: breastfeeding until the last trimester of pregnancy 
 
 
 
Table 2. Correlation between maternal zinc in plasma and  zinc in hair 
  Plasma Hair   
p*  
n = 29 n = 29 Correlation 
 
mean + SD mean + SD 
 
  µg/dL µg/g    
     Maternal zinc in hair  (ug/g) 60.5 + 8.3 153.48 + 52.5 -0.113 0.559 
          
* Bonferroni probabilities 
  The zinc concentration of the certified reference material, used to control the quality of the plasma  
  analysis, was 127 + 16 µg/dL (NIST) and the mean value obtained at the laboratory was 124 +  
  3.8  µg/dL.    
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Table 3.  Household appliances of SGA and their controls 
SGA Non-SGA 
P * n = 78 n = 150 
    n (%) n (%) 
Appliances at home 
Refrigerator 0.007 
Yes  15 (19.2) 55 (36.7) 
No 63 (80.8) 95 (63.3) 
Blender 0.009 
Yes  31 (39.7) 87 (58.0) 
No 47 (60.3) 63 (42.0) 
Television 0.951 
Yes  70 (89.7) 135 (90.0) 
No 8 (10.3) 15 (10.0) 
Radio 0.707 
Yes  49 (65.8) 98 (65.3) 
No 29 (37.2) 52 (34.7) 
Microwave oven 0.188 
Yes  2 (2.6) 10 (6.7) 
No 76 (97.4) 140 (93.3) 
Washing machine 0.188 
Yes  2 (2.6) 10 (6.7) 
No 76 (97.4) 140 (93.3) 
Sewing machine 0.955 
Yes  3 (3.8) 6 (4.0) 
No 75 (97.2) 144 (96.0) 
Computer 0.259 
Yes  1 (1.3) 6 (4.0) 
No 77 (98.7) 144 (96.0) 
Stereo 0.385 
Yes  11 (14.1) 28 (18.7) 
No   67 (85.9) 122 (81.3)   
* Pearson X2 was used for testing significant difference of proportions 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 4. Household members and food expenses by presence of SGA 
      
  SGA Non-SGA 
p†     n = 78 n = 150 
        mean + SD mean + SD 
Family members living at home, # 4.9 + 0.3 5.1 + 0.2 0.526 
Family members sleeping /room, # 3.1 + 0.1 3.0 + 0.1 0.492 
Money spent weekly on food per 
family member, S/.*       20.8 + 0.9         21.9 + 0.7 0.323 
              
 * 1 $ = 3.35 S/. 
 
† ANOVA was conducted for the comparison of means with the matched case-controls treated as blocks. 
SGA:  small for gestational age, < 10th percentile birth weight    
Non-SGA: 50th percentile > birth weight < 90th 
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Table 5. Maternal self reported diseases of SGA and their controls 
      
    SGA Non-SGA 
P *    n = 78 n = 150 
         n (%) n (%) 
Diabetes 0.470 
Before current pregnancy 0 0.0 0 0.0 
During current pregnancy 0 0.0 1 (0.7) 
Never 78 (100) 149 (99.3) 
High pressure 0.780 
Before current pregnancy 5 (6.4) 10 (6.7) 
During current pregnancy 6 (7.7) 8 (5.3) 
Never 67 (85.9) 132 (88.0) 
Asthma 0.641 
Before current pregnancy 5 (6.4) 6 (4.0) 
During current pregnancy 1 (1.3) 1 (0.7) 
Never 72 (92.3) 143 (95.3) 
Gastritis 
Before current pregnancy 18 (23.1) 24 (16.0) 0.380 
During current pregnancy 4 (5.1) 11 (7.3) 
Never 56 (71.8) 115 (76.7) 
Vaginitis 0.089 
Before current pregnancy 7 (9.0) 28 (18.7) 
During current pregnancy 48 (61.5) 91 (60.7) 
Never 23 (29.5) 31 (20.6) 
UTI 0.018 
Before current pregnancy 10 (12.8) 41 (27.3) 
During current pregnancy 35 (44.9) 45 (30.0) 
Never 33 (45.31) 64 (42.7) 
Pneumonia 0.693 
Before current pregnancy 4 (5.1) 6 (4.0) 
During current pregnancy 0 0.0 0 0.0 
Never     7 (94.9) 144 (96.0)   
* Pearson X2 was used for testing significant difference of proportions 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 5. Maternal self reported diseases of SGA and their controls (continue) 
      SGA Non-SGA 
P * n = 78 n = 150 
      n (%) n (%) 
Tuberculosis 0.086 
Before current pregnancy 5 (6.4) 3 (2.0) 
During current pregnancy 0 (0.0) 0 (0.0) 
Never 73 (93.6) 147 (98.0) 
Edema 0.077 
Before current pregnancy 3 (3.8) 20 (13.3) 
During current pregnancy 24 (30.8) 40 (26.7) 
Never 51 (65.4) 90 (60.0) 
Hepatitis 0.359 
Before current pregnancy 1 (1.3) 5 (3.3) 
During current pregnancy 0 (0.0) 0 (0.0) 
Never 77 (98.7) 145 (96.7) 
Typhoid 0.842 
Before current pregnancy 3 (3.8) 5 (3.3) 
During current pregnancy 0 (0.0) 0 (0.0) 
Never 75 (96.2) 145 (96.7) 
Morning sickness 0.605 
Before current pregnancy 8 (10.3) 20 (13.3) 
During current pregnancy 16 (20.5) 24 (16.0) 
Never 54 (69.2) 106 (70.7) 
Preeclampsia 0.551 
Before current pregnancy 6 (7.7) 13 (8.7) 
During current pregnancy 5 (6.4) 5 (3.3) 
Never 67 (85.9) 132 (88.0) 
Threat of abortion 0.727 
Before current pregnancy 12 (15.4) 28 (18.7) 
During current pregnancy 10 (12.8) 22 (14.6) 
Never     56 (71.8) 100 (66.7)   
* Pearson X2 was used for testing significant difference of proportions 
SGA:  small for gestational age, < 10th percentile birth weight   
Non-SGA: 50th percentile > birth weight < 90th 
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Table 6. Maternal food intake during pregnancy of SGA and their controls 
  
SGA Non-SGA 
p‡ n = 78 n = 150 
mean + SD mean + SD 
Monthly food frequency intake*      
Chicken   12.7 + 5.9 11.9 + 5.9 0.325 
Fish   6.7 + 4.7 6.4 + 4.8 0.637 
Other meat (beef, pork) 3.9 + 4.4 5.3 + 4.5 0.030 
Chicken liver  5.3 + 8.0 7.6 + 8.1 0.046 
Beef liver   1.7 + 2.7 2.0 + 2.7 0.491 
Other organ meat  2.4 + 2.6 2.8 + 2.6 0.254 
Shellfish   0.9 + 2.8 1.3 + 2.8 0.227 
Dairy products (milk, cheese, 
yogurt) 22.5 + 9.0 22.7 + 9.1 0.878 
Eggs   12.2 + 7.3 13.1 + 7.4 0.387 
Beans   8.9 + 4.2 8.6 + 4.3 0.660 
Quinua/wheat  2.2 + 2.9 2.8 + 2.9 0.190 
Rice   26.1 + 4.6 26.9 + 4.7 0.234 
Pasta   4.3 + 2.5 3.6 + 2.6 0.068 
Bread   26.9 + 6.6 28.1 + 6.7 0.169 
Vegetables   11.6 + 8.9 12.6 + 9.0 0.430 
Potato, cassava, sweet potato 22.5 + 8.3 22.7 + 8.4 0.889 
Fruits   24.6 + 8.1 25.0 + 8.1 0.712 
Number of meals + snacks per 
day† 4.19 + 0.9 4.12 + 0.9 0.603 
* Food consumption: means of  number of times per month. 
 
†
 cases n = 77  
 
‡
 ANOVA was conducted for the comparison of means with the matched case-controls treated as blocks. 
  SGA:  small for gestational age, < 10th percentile birth weight   
  Non-SGA: 50th percentile > birth weight < 90th 
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Table 7.  Household characteristics of PAPL and their controls 
    
   PAPL    Non-PAPL 
P 1    n =176   n = 347 
      n   (%) n   (%) 
Housing main material 0.425 
Bricks and cement 121 (68.8) 258 (74.8) 
Bricks 2 (1.1) 4 (1.2) 
Wood 30 (17.0) 43 (12.5) 
straw mats 3 (1.7) 10 (2.9) 
Others 20 (11.4) 30 (8.7) 
Housing source of light 0.322 
House connection 149 (84.7) 299 (86.7) 
Neighbor's 24 (13.6) 35 (10.1) 
Candles 3 (1.7) 11 (3.2) 
Housing  Source of water 0.560 
Potable water 139 (79.0) 277 (80.3) 
Public sink 7 (4.0) 9 (2.6) 
Tanker 18 (10.2) 39 (11.3) 
Neighbors 8 (4.6) 15 (4.4) 
Well 2 (1.1) 5 (1.4) 
Others 2 (1.1) 0 (0.0) 
Place use as a bathroom 0.102 
Toilet 140 (79.6) 286 (82.9) 
Outhouse with drain 12 (6.8) 7 (2.0) 
Outhouse  without 
drain 20 (11.4) 42 (12.2) 
Open land 2 (1.1) 4 (1.2) 
Others 2 (1.1) 6 (1.7) 
Fuel used for cooking 0.074 
Gas 142 (80.7) 283 (81.4) 
Kerosene 24 (13.7) 54 (15.7) 
Wood 5 (2.8) 9 (2.6) 
Others   5 (2.8) 1 (0.3)   
1
 Pearson X2 was used for testing significant difference of proportions 
PAPL: prolonged active phase of labor 
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Table 8. Household appliances of PAPL and their controls  
    PAPL  Non-PAPL 
P 1 n =176 n = 347 
    n (%) n (%) 
Appliances at home 
Refrigerator 0.418 
Yes 52 (29.5) 114 (33.0) 
No 124 (70.5) 231 (67.0) 
Blender 0.995 
Yes 98 (55.7) 192 (55.7) 
No 78 (44.3) 153 (44.3) 
Television 0.560 
Yes 160 (90.9) 308 (89.3) 
No 16 (9.1) 37 (10.7) 
Radio 0.605 
Yes 103 (58.5) 210 (60.9) 
No 73 (41.5) 135 (39.1) 
Microwave oven 0.934 
Yes 10 (5.7) 19 (5.5) 
No 166 (94.3) 326 (94.5) 
Washing machine 0.055 
Yes 8 (4.5) 32 (9.3) 
No 168 (95.5) 313 (90.7) 
Sewing machine 0.263 
Yes 5 (2.8) 17 (4.9) 
No 171 (97.2) 328 (95.1) 
Computer 0.699 
Yes 5 (2.8) 12 (4.5) 
No 171 (97.2) 333 (96.5) 
Stereo 0.276 
Yes 33 (18.7) 79 (22.9) 
No   143 (81.3) 266 (77.1)   
1
 Pearson X2 was used for testing significant difference of proportions                                     
PAPL: prolonged active phase of labor 
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Table 9. Household members and food expenses by presence of  PAPL 
      
  PAPL  Non-PAPL 
P 2     n = 176 n = 345 
        mean + SD mean + SD 
Number of family members living 
at home 4.8 + 2.2 4.7 + 2.2 0.792 
Number of family members 
sleeping in the same room 3.2 + 1.3 3.3 + 1.3 0.460 
Money spend weekly on food per 
family member, S/. 1  23.1 + 8.4 22.9 + 8.4 0.858 
1
 controls n = 344 
2
 1 $ = 3.35 S/. 
3
 ANOVA was conducted for the comparison of means with the matched case-controls treated as 
blocks 
PAPL: prolonged active phase of labor 
 
 
Table 10. Maternal and newborn vital functions during labor of PAPL and their 
controls 
        PAPL  Non-PAPL 
P 5     n = 176         n =  345 
        mean + SD       mean + SD 
Maternal pulse 1      
Maximum     85.1 + 6.5 83.2 + 6.5 0.002 
Minimum     75.6 + 5.7 76.8 + 5.7 0.029 
Maternal systolic arterial pressure 2    
Maximum     114.8 + 11.2  111.6 + 11.3 0.002 
Minimum          101.6 + 8.9      103.8 + 8.9 0.010 
Maternal diastolic arterial pressure 2    
Maximum     72.7 + 8.5  71.7 + 8.6 0.221 
Minimum     63.3 + 7.3  64.3 + 7.4 0.142 
Fetal cardiac frequency 3     
Maximum    148.7 + 4.8 146.8 + 4.8 0.000 
Minimum    136.8 + 4.8 138.3 + 4.8 0.001 
Estimated maternal bleeding 4    283.8 + 136.0  276.5 + 137.0 0.577 
1 controls n = 343 
     
2 controls n = 344 
     
3
 cases n = 175 controls n = 344 
    
4
 cases n = 166 controls n = 325 
5
 Pearson X2 was used for testing significant difference of proportions and ANOVA was conducted for the 
comparison of means with the matched case-controls treated as blocks. 
PAPL: prolonged active phase of labor. 
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Table 11. Maternal self reported diseases of PAPL and their controls 
      PAPL  Non-PAPL 
P 1 n = 176 n = 345 
      n (%) n (%) 
Diabetes 0.140 
Before current pregnancy 1 (0.6) 0 (0.0) 
During current pregnancy 1 (0.6) 0 (0.0) 
Never 174 (98.8) 345 (100) 
High pressure 0.601 
Before current pregnancy 16 (9.1) 23 (6.7) 
During current pregnancy 7 (4.0) 13 (3.8) 
Never 153 (86.9) 309 (89.6) 
Asthma 0.350 
Before current pregnancy 2 (1.1) 11 (3.2) 
During current pregnancy 3 (1.7) 7 (2.0) 
Never 171 (97.2) 327 (94.8) 
Gastritis 0.723 
Before current pregnancy 29 (16.5) 48 (13.9) 
During current pregnancy 13 (7.4) 28 (8.1) 
Never 134 (76.1) 269 (78.0) 
Vaginitis 0.770 
Before current pregnancy 26 (14.8) 55 (15.9) 
During current pregnancy 99 (56.2) 200 (58.0) 
Never 51 (29.0) 90 (26.1) 
UTI 0.194 
Before current pregnancy 42 (23.9) 72 (20.9) 
During current pregnancy 69 (30.2) 117 (33.9) 
Never 65 (36.9) 156 (45.2) 
Pneumonia 0.722 
Before current pregnancy 1 (0.6) 3 (0.9) 
During current pregnancy 0 (0.0) 1 (0.3) 
Never     175 (99.4) 341 (98.8)   
1
 Pearson X2 was used for testing significant difference of proportions 
  PAPL: prolonged active phase of labor 
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Table 11. Maternal self reported diseases of PAPL and their controls (continue) 
      PAPL  Non-PAPL 
P 1 
n = 176 n = 347 
      n (%) n (%) 
Tuberculosis 0.723 
Before current pregnancy 6 (3.4) 14 (4.1) 
During current pregnancy 0 (0.0) 1 (0.3) 
Never 170 (96.6) 330 (95.6) 
Edema 0.157 
Before current pregnancy 24 (13.6) 29 (8.4) 
During current pregnancy 45 (25.6) 87 (25.2) 
Never 107 (60.8) 229 (66.4) 
Hepatitis 0.605 
Before current pregnancy 6 (3.4) 9 (2.6) 
During current pregnancy 0 (0.0) 0 (0.0) 
Never 170 (96.6) 336 (97.4) 
Typhoid 0.291 
Before current pregnancy 4 (2.7) 14 (4.1) 
During current pregnancy 0 (0.0) 0 (0.0) 
Never 172 (97.7) 331 (95.9) 
Morning sickness 0.308 
Before current pregnancy 27 (15.3) 48 (13.9) 
During current pregnancy 32 (18.2) 47 (13.6) 
Never 117 (66.5) 250 (72.5) 
Threat of abortion 0.194 
Before current pregnancy 24 (13.7) 50 (14.5) 
During current pregnancy 14 (7.9) 45 (13.0) 
Never     138 (78.4) 250 (72.5)   
1
 Pearson X2 was used for testing significant difference of proportions 
  PAPL: prolonged active phase of labor 
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Table 12. Maternal food intake during pregnancy of PAPL and their controls 
Food 
             PAPL    Non-PAPL 
P 5               n = 176  n = 344 
mean + SD    mean + SD 
Monthly food frequency intake 
Chicken       12.4 + 5.8 12.5 + 5.8 0.813 
Fish 6.9 + 4.2 6.0  + 4.2 0.016 
Other meat (beef, pork) 2 5.1 + 4.2 5.1 + 4.2 0.990 
Chicken liver 2 7.2 + 7.0 6.2 + 7.0 0.113 
Beef liver   1.8 + 2.5 1.8 + 2.5 0.999 
Other organ meat   2.5 + 2.4 2.7 + 2.4 0.210 
Shellfish 3   1.3 + 2.2 1.0 + 2.2 0.162 
Dairy products (milk, cheese, yogurt) 22.3 + 8.9 23.4 + 8.9 0.178 
Eggs 12.6 + 7.8 13.1 + 7.8 0.503 
Beans  8.9 + 4.4 8.8 + 4.4 0.798 
Quinua/wheat  2.4 + 2.9 2.6 + 2.9 0.401 
Rice 27.0 + 3.6 27.0 + 3.6 0.897 
Pasta  3.7 + 2.2 3.7 + 2.2 0.896 
Bread 27.0 + 6.7 27.9 + 6.8 0.188 
Vegetables 12.0 + 8.0 13.0 + 8.0 0.177 
Potato, cassava, sweet potato 22.4 + 8.2 22.7 + 8.3 0.707 
Fruits 24.7 + 8.0 24.9 + 8.0 0.813 
Meals + snacks per day 4 4.1 + 0.9 4.13 + 0.9 0.860 
1 Food consumption: means of  number of times per month 
2 controls n = 343  
    
3 cases n = 175 
4
 controls n = 342 
5
 ANOVA was conducted for the comparison of means with the matched case-controls treated as   
  Controls. 
  PAPL: prolonged active phase of labor 
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APPENDIX B. SURVEY FORMATS 
Nº C.C. Date
DD MM YY
Interviewer: Code
Hospital
1. LWGA ________
2. PREM ________
3. DAP ________
1. Last child's age years months Date of birth
1a. Sex:  M___    F___  1b.  Name: 
2. How is your last child doing?
3. How have the last child reacted about your pregnancy?
4. Are you currently breastfeeding your last child? 1 = yes    2 = no
if the answer is no go to Nº 5
4a. Over the last week,  how often? day night total
4b. For how long will you continue breastfeeding?
4c. What is the main reason for your decision to continue breastfeeding?
4d. Who do you think had the most influence in your decision to continue breastfeeding 
 during pregnancy?
a. Myself d. Relative
b. Mother e. Friend
c. Child f. Health professional
d. Husband g. Other
5. If not breasfeeding, how old was your last child when weaned? months
5a. Overlap during pregnancy? 1 = yes   2 = no 5b. Until what month? 
Maternal Records
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Code
Hospital
5c. What was the main reason for your decision to not continue to breastfeed?
5d. How often did you used to breastfeed day night total
your child at the time of weaning? (Ask if mother overlaped during the third trimester of pregnancy)
5e. Who do you think had the most influence in your decision to not continue to breastfeed?
a. Myself d. Relative
b. Mother e. Friend
c. Child f. Health professional
d. Husband g. Other
6  Have you ever had any advice from a health professional regarding breastfeeding during pregnancy?
1 = yes    2 = no
6a. What did they tell you?
6b. Did you follow the recommendation? 1 = yes    2 = no
6c. What do you think of the recommendation? 
7.  Have you ever had any advice from a relative regarding breastfeeding during pregnancy?
1 = yes    2 = no
7a. What did they tell you?
7b. Did you follow the recommendation? 1 = yes    2 = no
7c. What do you think of the recommendation?
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Code
Hospital
8.  Have you ever had any advice from a friend regarding breastfeeding during pregnancy?
1 = yes    2 = no
8a. What did they tell you?
8b. Did you follow the recommendation? 1 = yes    2 = no
8c. What do you think of the recommendation?
9  Have you ever heard or seen  through mass media any advice regarding breastfeeding during pregnancy?
9a. What did you read or hear?
10. Do you have or have had any of the following diseases?
yes yes
no no
Diabetes Hepatitis
High pressure Typhoid
Asthma Morning sickness
Gastritis Preeclampsia
Vaginitis Threat of abortion
UTI Cancer
Pneumonia Epilepsy
TB Others:
Edema
88 = Not applicable
Enfermedad Before or Enfermedad Before orduring during
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Code
Hospital
11. Have you used medicaments during pregnancy? 1 = yes    2 = no
11a.Which ones?
12. Do you smoke ? 1 = yes    2 = no
12a. For how long have you smoked?
12b. How many cigarrettes do you smoke per month? 
12c. How many days per month? 
13. If not smoking, have you ever smoked? 1 = yes    2 = no
13a. How long ago did you quit smoking?
14. During your pregnancy, did you live or work with somebody who smoked? 1 = yes    2 = no
14b.Have they smoked in your presence? 1 = yes    2 = no
15.  Do you take any vitamins or minerals? 1 = yes    2 = no
 Which ones? How often? 
How often?   
How often?  
16. What recommendation would you give to a mother who is breastfeeding and becomes pregnant?
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Nº C.C. Date
DD MM YY
Interviewer: Code
Hospital
Mother status
1. Where were you born ?
2. Mother´s age: Date of birth
3. How long have you been living in Lima?
4. In what district do you live? 
5. What is your educational status? ____ ____ 
a. Not completed elementary school e. Not completed technical college
b. Completed elementary school f. Completed technical college  
c. Not completed high school g. Not completed college
d. Completed high school h. Completed college  
6. What is your marital status?
a. Married c. Single e. Separated
b. Live together d. Divorced f. Widowed
7. Do you work? 1 = yes    2 = no
7a. Inside / outside the home? 1= inside  2=outside
7b. What kind of work do you do?
7c. Self-employed or salaried? 1= self-employed  2= salaried
7d. What is your monthly income?
7e. Your contract is: 1= short term (< 6 months)  2= long term (> 6 months)
Sociodemographic Survey
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Code
Hospital
8. Have you worked during this last year? 1 = yes    2 = no
8a. How long ago did you stop working? months
8b. How much was your income?
9. Do you have health insurance? 1 = yes    2 = no
9a. What type?
1. ESSALUD 3. SIS
2. private 4. Other
10. What is your husband´s job?
House
1. The house where you live is:  
1. Own
2. Rented
3. Relative's
4. Other
2. What material is your house contructed of?
1. Bricks and cement 4. straw mats
2. Bricks 5. others
3. Wood
3. How do you light your house?
4. From where do you get the water to cook and to wash?
5. Where do you go to the bathroom (defecate)
6. What kind of fuel do you use for cooking?   
1 Gas 3 Electricity 6 others
2 Kerosene 4 Wood
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Code
Hospital
7. What appliances do you have in your house?
1. Refrigerator                      4. Radio 7. Sewing machine
2. Blender 5. Microwave oven 8. Computer
3. Television 6. Washing machine 9. Stereo
8. How many members does your family have?
members that share from the same familiar pot
Children Adolescents Adults
12 - 17y. > 18y.
9. How many rooms does your home have?
Exclude bathroom and kitchen
8a. How many rooms are used for sleeping?
10. How many of your family members work?
11. How many of your family members have a steady job?
with contract > 6 months
12. How much per week does your family spend on food?
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Nº C.C. Date
DD MM YY
Interviewer: Code
Hospital
1. Age years Date of birth
2. Height ____ ____ ____ . ____ cm
3. Weight before pregnancy ____ ____ ____ . ____ Kg.
4. Weight gained during pregnancy ____ ____ ____ . ____ Kg.
5. Pregnancies
miscarriage
< 2500
vaginal born alive
< 37 weeks           deliveries
cesarean born dead
Maternal Information From Clinical Chart 
Date of control Weight
twins
Kg
Gestational age
weeks
pregnancies
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Code
Hospital
6. Last child´s age years months Date of birth
7. Hemoglobin ___ ___ . ___ Date ____ / ____ / ____ 
___ ___ . ___ Date ____ / ____ / ____
8. HIV status Positive Negative Not done
9. Preeclamsia 1 = yes    2 = no
Labor Observations
Bleeding´s calculation ___ ___ ___ ___ ml
Membranes broken complete
Placenta´s weight ___ ___ ___ g
Spontaneous delivery 1 = yes    2 = no
Procedures: Forceps 1 = yes    2 = no
Vacuum 1 = yes    2 = no
Cesarean 1 = yes    2 = no
Mechonial liquid 1 = yes    2 = no
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No CC NB Date
DD MM YY
Interviewer: Code
No CC mother
1. Date of birth: Time: ___ ___ : ___ ___ 2. Sex: M __     F__
DD MM YY
3. Gestational age: ____ ____ weeks 3a.Method used to calculate:
4. Weight ____ ____ ____ ____ g 5. Length ____ ____ cm.
or height
6. Head circunference ____ ____ . ___ cm.
7. Torax circunference ____ ____ . ___ cm.
8. Apgar 1 min. ___       5 min. ____
Procedures 
1. Incubator 1 =yes  2=no
2. Nasogastric tube 1 =yes  2=no
3. Oxygen 1 =yes  2=no
4. Use of medication 1 =yes  2=no
5. Pathology 1 =yes  2=no
6. Malformations 1 =yes  2=no
Observations:
Medication Reason
Newborn's Information
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Nº C.C. Date
DD MM YY
Interviewer: Code
Hospital
HOSPITALIZATION
1. Admittance Date: ____ / ____ / ____ Time : ___ ___ : ___ ___
2. Examinations during labor
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
      /     /           :
FHRContractionsTimeDate
Freq. Intens. Durat.
Pulse
Labor Information
BP
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Code
Hospital
LABOR
1 Mother´s position at labor Vertical Horizontal 
2 Membranes Intact Broken 
3 Type of presentation right left 
First stage
1 Latent phase: Reported on C.C.: 1 =yes  2=no
Date start:   ____ / ____ / ____
Time start:    ___ ___ : ___ ___
Time end: ___ ___ : ___ ___ 
Total duration: ___ ___ 
Use of oxytocin: 1 =yes  2=no Use began at dilatation:  1    2    3
Dilution:     0.5%      1%       2%
Drops:       _____   _____   _____
Time:         _____   _____   _____
2 Active phase: Date start:   ____ / ____ / ____
       :        :
       :        :
       :        :
       :        :
       :        :
       :        :
Dilatation
cm
Total
Hour
begins
Hour
ends real (min)
Maximum Time
programmed (min)
Time 
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Code
Hospital
2a. Use of oxytocin: 1 =yes  2=no Use began at dilatation:  1    2    3
Dilution:     0.5%      1%       2%
Drops:       _____   _____   _____
Time:         _____   _____   _____
Observations:
2b. Artificial rupture of membranes: 1 =yes  2=no Dilatation:   4   5   6   7   8   9
Observations:
Second stage: Expulsion
Real time longer than programmed time 1 =yes  2=no Time in excess: ___ ___ min.
Spontaneous: 1 =yes  2=no
Procedures: Forceps 1 =yes  2=no
Vacuum 1 =yes  2=no
Cesarean 1 =yes  2=no
Observations:
Third stage: Childbirth
1. Estimate of bleeding: ___ ___ ___ ___  ml.
2. Placenta and umbilical cordon:
2a. Placenta's weight ___ ___ ___ g
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Code
Hospital
2b. Placenta´s morphology Complete cotyledons 1 =yes  2=no
Type of insertion
Complete membranes 1 =yes  2=no
2c. Umbilical cord Length ___ ___ cm
3. Mechonial liquid 1 =yes  2=no
Obstetric interventions
1. Episiotomy 1 =yes  2=no
2. Tears 1 =yes  2=no ID         IID        IIID
3. Medication 1 =yes  2=no
type: Time of use
Observations : 
Labor complications
1 =yes  2=no
Observations : 
Type of complication Moment of complication
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Nº C.C.
DD MM YY
Interviewer: Code
1. Have you changed your diet during pregnancy? 1 = yes    2 = no
2. At what moment?
1. 1º trimester 4. 1º y 2º trimester
2. 2º trimester 5. 2º y 3º trimester
3. 3º trimester 6. All pregnancy
2a. What changed?
3. How many times per day did you used to eat?
How many where snacks?
1 2 3 4 5 6 7
Chicken
Fish
Other meat (beef, pork)
Chicken liver
Beef liver
Other organ meat
Shellfish
Dairy products (milk, cheese, yogurt)
Eggs
Beans
Quinua/wheat
month
Intake Frequency
Times per week
pregnan.Food Never
TimesTimes
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Code
1 2 3 4 5 6 7
Rice
Pasta
Bread
Vegetables (not in soup or stew)
Potato, cassava, sweet potato
Fruits
Observations: 
Food Times per week Times Times
month pregnan. Never
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APPENDIX C. INFORMED CONSENT FORMS 
 
INFORMED CONSENT DOCUMENT 
 
Study of the practices during pregnancy among women who live in 
Lima. 
Investigators: 
Grace S. Marquis, PhD 
Philip Dixon, PhD 
 Rossina Pareja, Lic. 
 Iowa State University 
Ames, Iowa 50011; Telephone 515-294-9377 
Mary Penny, MD.  
Instituto de Investigación Nutricional 
Av. La Molina 1885 – La Molina; Teléfono 349-6023. 
 
 
This study is conducted by Iowa State University (USA) in coordination with the Nutrition 
Reasearch Institute (PERU) and the Hospital María Auxiliadora, Hospital Hipólito Unánue 
and Hospital Nacional Docente Madre Niño San Bartolomé. Please take your time in 
deciding if you would like to participate. Please feel free to ask any question. 
  
Introduction 
The Instituto de Investigación Nutricional is an Institution that has been working for more 
than 30 years in different areas of our country through projects of health and nutrition. In this 
opportunity we are obtaining information about feeding practices of pregnant women with 
their children. 
 
What is the study about? 
The purpose of this study is to examine the way that pregnant women care for their children 
so that we can develop sound recommendations to improve children’s lives.  
 
Who can participate in the study? 
Women who gave birth in this hospital and have a child younger than 4 years old can 
participate. 
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What I will be asked for if my child and I participate in the study? 
If you agree to participate in this study, your participation will involve one interview of 
approximately 30 minutes with our worker. In this interview you will be asked about 
characteristics of yourself and your household, your health, obstetric history, your diet and  
feeding practices with your youngest child, before you gave birth. When you are interviewed, 
you may skip any question that you do not wish to answer or that makes you feel 
uncomfortable. Additional information about you and your baby, such as obstetrical 
evaluation after admission, your delivery, your weight and height, newborn’s length and 
weight, will be taken from you and your baby’s clinical chart.  Finally, if you are chosen (at 
random), we will ask you for a small  
hair sample from you and your newborn as well as a sample of your breast milk (less than a 
tablespoon), to assess zinc status. If you agree, the results from the test will be given to the 
hospital to be posted in your clinical chart, so you can have access to them.   
 
Are there any risks for me or my baby if we participate in the study? 
There are no risks of participate in this study, since we will just obtain the necessary 
information from your answers, from your clinical record and if the case from your breast 
milk sample and hair.  
 
Is there any benefit for participating? 
There will not be direct benefits for you, but the information gained in this study would 
benefit society by providing valuable information for health professionals about pregnant 
women and their toddlers so they could develop accurate recommendations.  
Can I withdraw at any moment? 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time.  If you decide to not participate in the study or leave the study 
early, it will not result in any penalty or loss of benefits to which you are otherwise entitled, 
including services in this hospital. 
 
Confidentiality. Who will know about my identity or my child in the project? 
Records identifying participants will be kept confidential to the extent permitted by 
applicable laws and regulations and will not be made publicly available.   
To ensure confidentiality to the extent permitted by law, the following measures will be 
taken, each participant will be assigned a unique code that will be used instead of the name. 
Only investigators and supervisor in charge of the study will have access to records linking 
participants’ names and codes. Files linking participants’ name with a unique code will be 
destroyed at the end of the project.  If the results are published, your identity will remain 
confidential. 
 
Who should I call if I have questions about the project? 
You are encouraged to ask questions at any time during this study.  For further information 
about the study contact Lic. Rossina Pareja 3496023 rossipt@iastate.edu (PERU), Dr. Mary 
Penny 3496023 mpenny@iin.sld.pe (PERU), Dr. Grace Marquis (515) 294-9231 
gmarquis@iastate.edu  (USA).  If you have any questions about the rights of research 
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subjects or research-related injury, please contact the Instituto de Investigación Nutricional’s 
ethics committee, Dr. Enrique Morales 3496023 (Perú) or the Human Subjects Research 
Office, 1138 Pearson Hall, (515) 294-4566 austingr@iastate.edu (USA) or the Research 
Compliance Officer, Office of Research Compliance, 1138 Pearson Hall, (515) 294-3115; 
dament@iastate.edu (USA). 
 
 
Voluntary statement of informed consent form 
Your signature indicates that you voluntarily agree to participate in this study, that you 
authorize us to extract some information from your clinical chart, that the study has been 
explained to you, that you have been given the time to read the document and that your 
questions have been satisfactorily answered.  You will receive a copy of the signed and dated 
written informed consent prior to your participation in the study. 
 
Participant’s Name (printed)               
 
    
             
(Participant’s Signature/thumbprint)            (Date)  
 
Your signature below indicates that you voluntarily agree to allow your infant also to 
participate in this study. 
Infant’s Name (printed)               
 
    
             
(Mother’s Signature/thumbprint)                       (Date)  
 
 
Investigator statement 
I certify that the participant has been given adequate time to read and learn about the study 
and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this study 
and has voluntarily agreed to participate.    
 
             
(Signature of Person Obtaining Informed Consent)          (Date)   
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INFORMED CONSENT DOCUMENT 
 
Study of the practices during pregnancy among women who live in 
Lima. 
 
(Pre-post delivery cross-sectional study) 
 
Investigators: 
Grace S. Marquis, PhD 
Philip Dixon, PhD 
 Rossina Pareja, Lic. 
 Iowa State University 
Ames, Iowa 50011; Telephone 001-515-294-9377 
 
Mary Penny, MD.  
Instituto de Investigación Nutricional 
Av. La Molina 1885 – La Molina; Teléfono 349-6023. 
 
 
This study is conducted by Iowa State University (USA) in coordination with the Nutrition 
Research Institute (PERU). Please take your time in deciding if you would like to participate. 
Please feel free to ask any question. 
  
 
Introduction 
The Instituto de Investigación Nutricional is an institution that has been working for more 
than 30 years in different areas of our country through projects of health and nutrition. In this 
opportunity we are obtaining information about the zinc values in pregnant women. 
 
What is the study about? 
The present is part of an study that currently is being conducted at 3 hospitals in Lima 
Metroplolitana, where we are taking hair samples from mothers who give birth and have a 
child younger than 4 years, to evaluate their zinc nutritional status. The zinc is a very 
important mineral for all stages of life, especially at times when rapid growth takes place, 
such as during pregnancy, where the formation and growth of a new human being takes 
place. Therefore the purpose of this study is to explore if the values of zinc obtained from 
hair samples taken after delivery reflect or are associated with the values of zinc obtained  
from blood during the last trimester of pregnancy. 
 
Who can participate in the study? 
Women who are in the 7th month of pregnancy and have child younger than 4 years old can 
participate. 
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What I will be asked for if I participate in the study? 
If you agree to participate in this study, a fieldworker will visit you at home on two 
occasions, the first during your 7th month of pregnancy. At that time you will be asked for a 
blood sample of approximately 7ml. ( less than a tablespoon). The second visit will be after 
you give birth when you will be asked for a hair sample (a small lock of hair). The results of 
the tests will be given to you when they are ready.  
 
Are there any risks for me if I participate in the study? 
There are no risks for participating in this study.  The taking of blood sample may cause 
minor localized discomfort. 
 
Is there any benefit for participating? 
A benefit for you will be that you will know your zinc nutritional status; additionally we shall 
give you your iron nutritional status and your blood type. Besides that, the information 
gained in this study will benefit society by providing valuable information to evaluate the 
zinc nutritional status in pregnant women.  
Can I withdraw at any moment? 
Your participation in this study is completely voluntary and you may refuse to participate or 
leave the study at any time.  If you decide not to participate in the study or leave the study 
early, it will not result in any penalty or loss of benefits to which you are otherwise entitled. 
 
Confidentiality. Who will know about my identity in the project? 
Any information that you give us about you or your baby will be confidential and kept it in a 
locked cabinet at the IIN. To ensure confidentiality to the extent permitted by law, the 
following measures will be taken: each participant will be assigned a unique code that will be 
used instead of the name. Only investigators and supervisors in charge of the study will have 
access to records linking participants’ names and codes. Files linking participants’ name with 
a unique code will be destroyed at the end of the project.  If the results are published, your 
identity will remain confidential. 
 
Who should I call if I have questions about the project? 
You are encouraged to ask questions at any time during this study.  For further information 
about the study contact Lic. Rossina Pareja 3496023 rossipt@iastate.edu (PERU), Dr. Mary 
Penny 3496023 mpenny@iin.sld.pe (PERU), Dr. Grace Marquis (001-515) 294-9231 
gmarquis@iastate.edu  (USA).  If you have any questions about the rights of research 
subjects or research-related injury, please contact the Instituto de Investigación Nutricional’s 
ethics committee, Dr. Enrique Morales 3496023 (Perú) or the Human Subjects Research 
Office, 1138 Pearson Hall, (001-515) 294-4566 austingr@iastate.edu (USA) or the Research 
Compliance Officer, Office of Research Compliance, 1138 Pearson Hall, (001-515) 294-
3115; dament@iastate.edu (USA). 
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Voluntary statement of informed consent form 
Your signature indicates that you voluntarily agree to participate in this study, that you 
authorize us to extract some information from your clinical chart, that the study has been 
explained to you, that you have been given the time to read the document and that your 
questions have been satisfactorily answered.  You will receive a copy of the signed and dated 
written informed consent prior to your participation in the study. 
 
Participant’s Name (printed)               
 
    
             
(Participant’s Signature/thumbprint)            (Date)  
 
 
Investigator statement 
I certify that the participant has been given adequate time to read and learn about the study 
and all of their questions have been answered.  It is my opinion that the participant 
understands the purpose, risks, benefits and the procedures that will be followed in this study 
and has voluntarily agreed to participate.    
 
             
(Signature of Person Obtaining Informed Consent)          (Date)   
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APPENDIX D. TABLE OF BIRTH WEIGHT FOR GESTATIONAL AGE 
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APPENDIX E. PARTOGRAPH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
